Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microfilament motor activity	MYH1 MYH2 MYH4 MYH8 MYO1A MYO3A	1.87e-06	38	198	6	GO:0000146
GeneOntologyMolecularFunction	actin filament binding	MYH1 MYH2 MYH4 MYH8 MYO1A ACTN1 NEB MYO3A CYFIP1 NRAP EEF2	1.73e-05	227	198	11	GO:0051015
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH1 MYH2 MYH4 MYH8 MYO1A MYO3A KIF2C KIF23	2.34e-05	118	198	8	GO:0003774
GeneOntologyMolecularFunction	cytoskeletal protein binding	MYH1 MYH2 MYH4 MYH8 DCDC1 MYO1A ACTN1 NEB EPB41L3 RAB8A FABP3 MYO3A CYFIP1 AP1G1 MAP4K4 KIF2C KIF23 NRAP ARFGEF2 DPYSL4 AGBL4 EEF2 CEP295 LYN EPB41	9.28e-05	1099	198	25	GO:0008092
GeneOntologyMolecularFunction	UDP-glucosyltransferase activity	POGLUT3 GYG1 UGGT2	2.55e-04	13	198	3	GO:0035251
GeneOntologyMolecularFunction	calmodulin binding	MYH1 MYH2 MYH4 MYH8 MYO1A RYR3 MYO3A CACNA1S EPB41	4.99e-04	230	198	9	GO:0005516
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	DAB2IP GDI1 THG1L SIPA1L2 DOCK6 ELMOD1 ACAP3 TNS3 PLEKHG4 DOCK9 ARFGEF2 RGS12 RGS6 THY1	5.58e-04	507	198	14	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	DAB2IP GDI1 THG1L SIPA1L2 DOCK6 ELMOD1 ACAP3 TNS3 PLEKHG4 DOCK9 ARFGEF2 RGS12 RGS6 THY1	5.58e-04	507	198	14	GO:0030695
GeneOntologyBiologicalProcess	vesicle coating	TRAPPC1 TRAPPC13 PEF1 TMED10 AP3D1 TRAPPC10	2.12e-06	40	198	6	GO:0006901
GeneOntologyBiologicalProcess	vesicle budding from membrane	TRAPPC1 TRAPPC13 PEF1 AP1G1 TMED10 AP3D1 TRAPPC10	2.77e-05	91	198	7	GO:0006900
GeneOntologyBiologicalProcess	positive regulation of neurotrophin TRK receptor signaling pathway	CYFIP1 CYFIP2 PPP2R5B	4.71e-05	8	198	3	GO:0051388
GeneOntologyBiologicalProcess	nucleobase-containing small molecule metabolic process	MYH4 MYH8 GALE ACLY INSR PGK2 SULT1C3 CDADC1 DLG2 GMPR DLST TALDO1 GPD2 DPYD DPYSL4 ENTPD4 MTHFD1 SLC25A13 UGGT2 ACSL5	5.20e-05	767	198	20	GO:0055086
GeneOntologyBiologicalProcess	purine-containing compound metabolic process	MYH4 MYH8 GALE ACLY INSR PGK2 SULT1C3 DLG2 GMPR DLST TALDO1 GPD2 DPYD ENTPD4 SLC17A1 MTHFD1 SLC25A13 ACSL5	6.09e-05	652	198	18	GO:0072521
GeneOntologyBiologicalProcess	cell morphogenesis	DAB2IP EPHB3 ENPP2 ACTN1 EPB41L3 GDI1 RAB8A MET KIRREL3 MYO3A CYFIP1 PCDH15 NTN1 MAP4K4 SEMA4B PLEKHG4 CLIC4 SPG11 TECTA CYFIP2 LIFR THY1 LZTS1 PRKDC LYN EPB41	8.01e-05	1194	198	26	GO:0000902
GeneOntologyCellularComponent	muscle myosin complex	MYH1 MYH2 MYH4 MYH8	1.38e-05	16	201	4	GO:0005859
GeneOntologyCellularComponent	myosin complex	MYH1 MYH2 MYH4 MYH8 MYO1A MYO3A	2.16e-05	59	201	6	GO:0016459
GeneOntologyCellularComponent	myosin filament	MYH1 MYH2 MYH4 MYH8	8.96e-05	25	201	4	GO:0032982
GeneOntologyCellularComponent	myosin II complex	MYH1 MYH2 MYH4 MYH8	1.42e-04	28	201	4	GO:0016460
GeneOntologyCellularComponent	actin cytoskeleton	MYH1 MYH2 MYH4 MYH8 MYO1A ACTN1 NEB MYO3A NTN1 VCAM1 TNS3 FLT1 TOPBP1 ANKRD62 CLIC4 EPB41	1.50e-04	576	201	16	GO:0015629
GeneOntologyCellularComponent	sarcomere	MYH1 MYH2 MYH4 MYH8 ACTN1 NEB RYR3 CACNA1S NRAP ANXA5	1.56e-04	249	201	10	GO:0030017
GeneOntologyCellularComponent	TRAPPII protein complex	TRAPPC1 TRAPPC13 TRAPPC10	1.81e-04	12	201	3	GO:1990071
GeneOntologyCellularComponent	myofibril	MYH1 MYH2 MYH4 MYH8 ACTN1 NEB RYR3 CACNA1S NRAP ANXA5	3.25e-04	273	201	10	GO:0030016
GeneOntologyCellularComponent	cilium	IFT140 PDE6A PGK2 RAB8A CC2D2B MET SLC9B1 CFAP54 KCNU1 PCDH15 CPLANE1 ELMOD1 VDAC2 HSPD1 ARFGEF2 PRAMEF17 EFHC2 AGBL4 PPP3R2 BBS7	4.32e-04	898	201	20	GO:0005929
GeneOntologyCellularComponent	contractile muscle fiber	MYH1 MYH2 MYH4 MYH8 ACTN1 NEB RYR3 CACNA1S NRAP ANXA5	5.23e-04	290	201	10	GO:0043292
GeneOntologyCellularComponent	TRAPP complex	TRAPPC1 TRAPPC13 TRAPPC10	5.39e-04	17	201	3	GO:0030008
GeneOntologyCellularComponent	trans-Golgi network transport vesicle	SYNRG RAB8A AP1G1 TMED10	5.78e-04	40	201	4	GO:0030140
GeneOntologyCellularComponent	vesicle tethering complex	TRAPPC1 TRAPPC13 COG5 VPS8 TRAPPC10	6.49e-04	72	201	5	GO:0099023
GeneOntologyCellularComponent	lysosome	ACLY VPS13C INSR TRAPPC1 AP1G1 AP3D1 IFITM1 SPG11 IFITM2 IDS MCOLN1 ENTPD4 EPG5 ARG1 SLC46A3 LNPEP GYG1 LYN	8.74e-04	811	201	18	GO:0005764
GeneOntologyCellularComponent	lytic vacuole	ACLY VPS13C INSR TRAPPC1 AP1G1 AP3D1 IFITM1 SPG11 IFITM2 IDS MCOLN1 ENTPD4 EPG5 ARG1 SLC46A3 LNPEP GYG1 LYN	8.74e-04	811	201	18	GO:0000323
GeneOntologyCellularComponent	anchoring junction	MYH1 MYH2 HSP90B1 ACTN1 EPB41L3 KIRREL3 CYFIP1 DLG2 MAP4K4 TNS3 MPP7 FLT1 KIF23 NRAP ANXA5 CLIC4 PIKFYVE TGFBR1 THY1 LYN	1.21e-03	976	201	20	GO:0070161
GeneOntologyCellularComponent	vacuole	ACLY VPS13C INSR TRAPPC1 AP1G1 AP3D1 IFITM1 SPG11 IFITM2 GLB1L2 IDS MCOLN1 ENTPD4 EPG5 ARG1 SLC46A3 LNPEP GYG1 LYN	1.34e-03	913	201	19	GO:0005773
GeneOntologyCellularComponent	super elongation complex	AFF1 AFF3	1.35e-03	6	201	2	GO:0032783
GeneOntologyCellularComponent	U2AF complex	U2AF1L4 U2AF1	1.87e-03	7	201	2	GO:0089701
Domain	Myosin_head_motor_dom	MYH1 MYH2 MYH4 MYH8 MYO1A MYO3A	2.99e-06	38	201	6	IPR001609
Domain	MYOSIN_MOTOR	MYH1 MYH2 MYH4 MYH8 MYO1A MYO3A	2.99e-06	38	201	6	PS51456
Domain	Myosin_head	MYH1 MYH2 MYH4 MYH8 MYO1A MYO3A	2.99e-06	38	201	6	PF00063
Domain	MYSc	MYH1 MYH2 MYH4 MYH8 MYO1A MYO3A	2.99e-06	38	201	6	SM00242
Domain	IQ	MYH1 MYH2 MYH4 MYH8 MYO1A MYO3A UBE3B	1.12e-05	71	201	7	PF00612
Domain	P-loop_NTPase	MYH1 MYH2 MYH4 MYH8 ERCC2 MYO1A ATRX RAB8A MYO3A SULT1C3 SEPTIN14 SRL DLG2 DHX29 MPP7 KIF2C CHST3 KIF23 ARL9 GFM2 EEF2 MTHFD1 YLPM1 WSCD2	1.50e-05	848	201	24	IPR027417
Domain	Myosin_N	MYH1 MYH2 MYH4 MYH8	1.62e-05	15	201	4	PF02736
Domain	Myosin_N	MYH1 MYH2 MYH4 MYH8	1.62e-05	15	201	4	IPR004009
Domain	IQ	MYH1 MYH2 MYH4 MYH8 MYO1A MYO3A UBE3B	2.67e-05	81	201	7	SM00015
Domain	Myosin_tail_1	MYH1 MYH2 MYH4 MYH8	3.54e-05	18	201	4	PF01576
Domain	Myosin_tail	MYH1 MYH2 MYH4 MYH8	3.54e-05	18	201	4	IPR002928
Domain	EF-hand_1	ACTN1 RYR3 EPS15L1 PEF1 CAPS2 GPD2 EFHC2 PPP3R2 SLC25A13	4.03e-05	152	201	9	PF00036
Domain	Myosin-like_IQ_dom	MYH1 MYH2 MYH4 MYH8	4.45e-05	19	201	4	IPR027401
Domain	-	MYH1 MYH2 MYH4 MYH8	4.45e-05	19	201	4	4.10.270.10
Domain	IQ_motif_EF-hand-BS	MYH1 MYH2 MYH4 MYH8 MYO1A MYO3A UBE3B	5.29e-05	90	201	7	IPR000048
Domain	IQ	MYH1 MYH2 MYH4 MYH8 MYO1A MYO3A UBE3B	6.53e-05	93	201	7	PS50096
Domain	Cytoplasmic_FMR1-int	CYFIP1 CYFIP2	1.15e-04	2	201	2	IPR008081
Domain	FragX_IP	CYFIP1 CYFIP2	1.15e-04	2	201	2	PF05994
Domain	A2M	CD109 C5 PZP	1.39e-04	10	201	3	PF00207
Domain	A2M_N_2	CD109 C5 PZP	1.39e-04	10	201	3	IPR011625
Domain	A2M_comp	CD109 C5 PZP	1.39e-04	10	201	3	IPR011626
Domain	A2M_recep	CD109 C5 PZP	1.39e-04	10	201	3	PF07677
Domain	A2M_comp	CD109 C5 PZP	1.39e-04	10	201	3	PF07678
Domain	A2M_N	CD109 C5 PZP	1.39e-04	10	201	3	PF01835
Domain	A2M_N	CD109 C5 PZP	1.39e-04	10	201	3	IPR002890
Domain	A-macroglobulin_rcpt-bd	CD109 C5 PZP	1.39e-04	10	201	3	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	CD109 C5 PZP	1.39e-04	10	201	3	PS00477
Domain	A2M_N_2	CD109 C5 PZP	1.39e-04	10	201	3	PF07703
Domain	Macroglobln_a2	CD109 C5 PZP	1.39e-04	10	201	3	IPR001599
Domain	EF-hand-dom_pair	SYNRG ACTN1 RYR3 EPS15L1 PEF1 CAPS2 GPD2 CACNA1S EFHC2 PPP3R2 SLC25A13	2.90e-04	287	201	11	IPR011992
Domain	-	SYNRG ACTN1 RYR3 EPS15L1 PEF1 CAPS2 GPD2 EFHC2 PPP3R2 SLC25A13	5.48e-04	261	201	10	1.10.238.10
Domain	Nebulin	NEB NRAP	6.82e-04	4	201	2	PF00880
Domain	4_1_CTD	EPB41L3 EPB41	6.82e-04	4	201	2	PF05902
Domain	NEBULIN	NEB NRAP	6.82e-04	4	201	2	PS51216
Domain	DUF1394	CYFIP1 CYFIP2	6.82e-04	4	201	2	IPR009828
Domain	SAB	EPB41L3 EPB41	6.82e-04	4	201	2	PF04382
Domain	BK_channel_a	KCNU1 KCNT1	6.82e-04	4	201	2	PF03493
Domain	NEBU	NEB NRAP	6.82e-04	4	201	2	SM00227
Domain	DUF1394	CYFIP1 CYFIP2	6.82e-04	4	201	2	PF07159
Domain	Nebulin	NEB NRAP	6.82e-04	4	201	2	IPR013998
Domain	EFG_IV	GFM2 EEF2	6.82e-04	4	201	2	SM00889
Domain	Band_4.1_C	EPB41L3 EPB41	6.82e-04	4	201	2	IPR008379
Domain	K_chnl_Ca-activ_BK_asu	KCNU1 KCNT1	6.82e-04	4	201	2	IPR003929
Domain	SAB_dom	EPB41L3 EPB41	6.82e-04	4	201	2	IPR007477
Domain	TF_AF4/FMR2	AFF1 AFF3	6.82e-04	4	201	2	IPR007797
Domain	Nebulin_repeat	NEB NRAP	6.82e-04	4	201	2	IPR000900
Domain	EFG_IV	GFM2 EEF2	6.82e-04	4	201	2	PF03764
Domain	Transl_elong_EFG/EF2_IV	GFM2 EEF2	6.82e-04	4	201	2	IPR005517
Domain	AF-4	AFF1 AFF3	6.82e-04	4	201	2	PF05110
Domain	Terpenoid_cyclase/PrenylTrfase	CD109 C5 PZP	8.89e-04	18	201	3	IPR008930
Domain	EF_HAND_2	ACTN1 RYR3 EPS15L1 PEF1 CAPS2 GPD2 EFHC2 PPP3R2 SLC25A13	9.17e-04	231	201	9	PS50222
Domain	EF_hand_dom	ACTN1 RYR3 EPS15L1 PEF1 CAPS2 GPD2 EFHC2 PPP3R2 SLC25A13	9.45e-04	232	201	9	IPR002048
Domain	-	GMPR TALDO1 DPYD TYW1B	1.06e-03	42	201	4	3.20.20.70
Domain	U2AF_small	U2AF1L4 U2AF1	1.13e-03	5	201	2	IPR009145
Domain	EFG_II	GFM2 EEF2	1.13e-03	5	201	2	PF14492
Domain	Aldolase_TIM	GMPR TALDO1 DPYD TYW1B	1.26e-03	44	201	4	IPR013785
Domain	EFh	ACTN1 EPS15L1 PEF1 CAPS2 GPD2 PPP3R2 SLC25A13	1.64e-03	158	201	7	SM00054
Domain	EFG_C	GFM2 EEF2	1.68e-03	6	201	2	PF00679
Domain	DUF3398	DOCK6 DOCK9	1.68e-03	6	201	2	PF11878
Domain	EFG_III-V	GFM2 EEF2	1.68e-03	6	201	2	IPR009022
Domain	EFG_C	GFM2 EEF2	1.68e-03	6	201	2	SM00838
Domain	DOCK_C/D_N	DOCK6 DOCK9	1.68e-03	6	201	2	IPR021816
Pubmed	mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.	HSP90B1 ACLY ACTN1 CYFIP1 ALB TMED10 TALDO1 VDAC2 SFN HSPD1 GPD2 RARS1 GRB10 ARG1 EEF2 MTHFD1 PRKDC	5.42e-12	312	203	17	37120454
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	MYH1 MYH2 MYH4 HSP90B1 MYH8 MYO1A ACLY ACTN1 GDI1 NUP210 DLST PZP TNS3 VDAC2 SFN HSPD1 RARS1 ANXA5 EEF2 MTHFD1 SLC25A13 UBR3 PRKDC	5.93e-12	647	203	23	26618866
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	KDM5B HSP90B1 EPB41L3 STT3A U2AF1 GAR1 SUPT5H PCDH15 DLST ALB SIPA1L2 PZP DOCK6 MAP4K4 AP3D1 VDAC2 HSPD1 GPD2 ANXA5 DPYSL4 ARG1 EEF2 SCG3 SLC25A13 YLPM1 RBM5 PRKDC IK SNRPD2	8.89e-12	1082	203	29	38697112
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	HSP90B1 ATRX ACLY VPS13C EPB41L3 STT3A U2AF1 PEF1 CYFIP1 GAR1 AP1G1 SUPT5H NUP210 DLST MAP4K4 TALDO1 DHX29 VDAC2 HSPD1 GPD2 KIF23 POLR1A RARS1 ANXA5 CYFIP2 EEF2 MTHFD1 SLC25A13 MTR RBM5 PRKDC IK SNRPD2	1.40e-11	1425	203	33	30948266
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH1 MYH2 MYH4 HSP90B1 MYH8 PDE6A MYO1A ATRX ACTN1 NEB EPB41L3 PGK2 RAB8A GAR1 DLG2 DLST TMPRSS7 SIPA1L2 AP3D1 SFN HSPD1 SPG11 UBLCP1 CYFIP2 EEF2 SCG3 SLC25A13 YLPM1 FAM169A RBM5 UGGT2 CEP295 PRKDC	1.91e-11	1442	203	33	35575683
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	HSP90B1 POGLUT3 ACLY CD109 U2AF1L4 EPB41L3 STT3A RAB8A MGAT2 AP1G1 DLST TMED10 MAP4K4 AP3D1 VDAC2 HSPD1 GPD2 SEMA4B IFITM1 IFITM2 GFM2 CYFIP2 EEF2 LNPEP VWA5A ASXL3 UGGT2 LSM2 SNRPD2 ACSL5 RAVER1	4.50e-10	1451	203	31	30550785
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	GALE ACTN1 EPB41L3 GDI1 STT3A EPS15L1 CYFIP1 AP1G1 SUPT5H DLST TMED10 COG5 TALDO1 DHX29 TNS3 VDAC2 SFN KIF2C GPD2 KIF23 DPYSL4 CLIC4 UBLCP1 ARG1 EEF2 GYG1 YLPM1 PRKDC SNRPD2 EPB41	4.74e-10	1367	203	30	32687490
Pubmed	MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1.	HSP90B1 GALE ACLY ACTN1 MET ALB HSPD1 GPD2 RARS1 EEF2 MTHFD1 SLC25A13	9.02e-10	182	203	12	30711629
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	HSP90B1 GALE ACLY INSR U2AF1L4 GDI1 U2AF1 CYFIP1 AFF1 HECTD1 TALDO1 TNS3 VDAC2 SFN HSPD1 KIF23 RARS1 ANXA5 CYFIP2 EEF2 MTHFD1 SLC25A13 TRAPPC10 PRKDC IK LYN SNRPD2 RAVER1	1.16e-09	1247	203	28	27684187
Pubmed	Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development.	MYH1 MYH2 MYH4 MYH8	5.61e-09	5	203	4	12919077
Pubmed	Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro.	MYH1 MYH2 MYH4 MYH8	5.61e-09	5	203	4	3829126
Pubmed	Sequential accumulation of mRNAs encoding different myosin heavy chain isoforms during skeletal muscle development in vivo detected with a recombinant plasmid identified as coding for an adult fast myosin heavy chain from mouse skeletal muscle.	MYH1 MYH2 MYH4 MYH8	5.61e-09	5	203	4	6196357
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	HSP90B1 ACLY ACTN1 EPB41L3 GDI1 TRAPPC1 U2AF1 EPS15L1 CYFIP1 AP1G1 DLG2 DLST ALB SIPA1L2 DHX29 AP3D1 VDAC2 HSPD1 GPD2 ARFGEF2 DPYSL4 CYFIP2 AGBL4 EEF2 THY1 LZTS1 MTHFD1 TRAPPC10 SNRPD2	5.69e-09	1431	203	29	37142655
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	HSP90B1 ACLY CD109 ACTN1 GDI1 STT3A U2AF1 CYFIP1 GAR1 NUP210 DLST ALB VDAC2 SFN KIF2C HSPD1 KIF23 RARS1 ARG1 EEF2 MTHFD1 SLC25A13 PRKDC IK LYN SNRPD2 RAVER1	6.02e-09	1257	203	27	36526897
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	NEB EPB41L3 RYR3 CYFIP1 GAR1 MAP4K4 AP3D1 KIF2C DPYD FLT1 POLR1A DOCK9 SPG11 RGS12 MTHFD1 SLC25A13 IK	6.85e-09	497	203	17	36774506
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	HSP90B1 VPS13C ACTN1 GDI1 ALB CPLANE1 MAP4K4 VDAC2 SFN KIF2C HSPD1 UBE3B ARFGEF2 GRB10 PRAMEF17 ARG1 EEF2 PRKDC	7.10e-09	564	203	18	21565611
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	HSP90B1 ACLY EPB41L3 STT3A EPS15L1 CYFIP1 MAP4K4 DHX29 AP3D1 MPP7 VDAC2 KIF2C HSPD1 GPD2 EEF2 MTHFD1 SLC25A13 PLEKHA1 PRKDC EPB41	7.82e-09	708	203	20	39231216
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	HSP90B1 ACLY INSR ACTN1 U2AF1 GAR1 SUPT5H NUP210 ALB MAP4K4 HSPD1 GPD2 POLR1A RARS1 ANXA5 ARG1 MTHFD1 BBS7 SLC25A13 YLPM1 PRKDC IK LYN SNRPD2	8.73e-09	1024	203	24	24711643
Pubmed	Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.	ACLY EPB41L3 STT3A U2AF1 GAR1 ALB VDAC2 HSPD1 RARS1 EEF2 MTHFD1 SLC25A13 RBM5 PRKDC SNRPD2	9.15e-09	383	203	15	29331416
Pubmed	Distinct myogenic programs of embryonic and fetal mouse muscle cells: expression of the perinatal myosin heavy chain isoform in vitro.	MYH1 MYH2 MYH4 MYH8	1.67e-08	6	203	4	1728586
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH1 MYH2 MYH4 MYH8	1.67e-08	6	203	4	10077619
Pubmed	Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development.	MYH1 MYH2 MYH4 MYH8	1.67e-08	6	203	4	10588881
Pubmed	Defining the membrane proteome of NK cells.	HSP90B1 ACLY STT3A EPS15L1 MGAT2 AP1G1 NUP210 PXMP2 DLST COG5 AP3D1 KIF2C HSPD1 RARS1 DOCK9 ANXA5 ARFGEF2 IFITM1 CYFIP2 EEF2 MTHFD1 LNPEP GYG1 PRKDC ACSL5	2.48e-08	1168	203	25	19946888
Pubmed	A genome-wide IR-induced RAD51 foci RNAi screen identifies CDC73 involved in chromatin remodeling for DNA repair.	HSP90B1 ACTN1 RAB8A ALB SFN HSPD1 RARS1 EEF2 MTHFD1 PRKDC	2.56e-08	153	203	10	27462432
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	HSP90B1 ACLY ACTN1 EPB41L3 CYFIP1 AP1G1 DLST DHX29 AP3D1 TNS3 VDAC2 KIF2C HSPD1 KIF23 POLR1A RARS1 PLEKHG4 ANXA5 ADNP2 CLIC4 ARG1 EEF2 MTHFD1 SLC25A13 PRKDC IK SNRPD2	2.77e-08	1353	203	27	29467282
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	HSP90B1 ACLY ACTN1 EPB41L3 RAB8A EPS15L1 AP1G1 MAP4K4 VDAC2 SFN HSPD1 GPD2 EEF2 THY1 MTHFD1 SLC25A13 SETBP1 LYN	3.08e-08	621	203	18	22794259
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH1 MYH2 MYH4 MYH8	3.89e-08	7	203	4	35210422
Pubmed	Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts.	MYH1 MYH2 MYH4 MYH8	3.89e-08	7	203	4	16819597
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	HSP90B1 POGLUT3 ERCC2 ACLY CD109 STT3A RAB8A MET U2AF1 CYFIP1 NUP210 TMED10 HECTD1 AP3D1 HSPD1 KIF23 RARS1 IFITM1 UBLCP1 EEF2 MTHFD1 LNPEP UGGT2 PRKDC LYN RAVER1	4.69e-08	1297	203	26	33545068
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	HSP90B1 POGLUT3 CD109 STT3A MET NUP210 ALB TMED10 TRHDE LNPEP	4.94e-08	164	203	10	32409323
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	POGLUT3 VPS13C STT3A PEF1 TMED10 HECTD1 MAP4K4 TNS3 KIF23 POLR1A SPG11 PIKFYVE IBTK BBS7 YLPM1 MTR RBM5 UGGT2 CEP295	7.26e-08	733	203	19	34672954
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	HSP90B1 ACLY ACTN1 U2AF1 GAR1 SUPT5H VDAC2 SFN KIF2C HSPD1 GPD2 KIF23 RARS1 CLIC4 EEF2 MTHFD1 SLC25A13 YLPM1 RBM5 PRKDC IK SNRPD2	9.41e-08	989	203	22	36424410
Pubmed	An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells.	HSP90B1 ACTN1 GDI1 TMED10 TALDO1 VDAC2 HSPD1 ANXA5 CLIC4 IFITM2 EEF2 MTHFD1 PRKDC SNRPD2	1.06e-07	397	203	14	21319273
Pubmed	PKCε promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria.	HSP90B1 ACTN1 TMED10 VDAC2 SFN HSPD1 ANXA5 EEF2 SLC25A13	1.16e-07	136	203	9	22304920
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	HSP90B1 ACLY ACTN1 GDI1 EPS15L1 CYFIP1 AP1G1 SUPT5H THG1L COG5 HECTD1 TALDO1 AP3D1 TNS3 SFN HSPD1 CACNA1S RARS1 ARFGEF2 EEF2 MTHFD1 LNPEP MTR NCOA7 PRKDC LSM2 SNRPD2	1.20e-07	1455	203	27	22863883
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	SYNRG TRAPPC1 TRAPPC13 EPS15L1 AP1G1 AFF1 AP3D1 VPS8 PIKFYVE LNPEP TRAPPC10 PLEKHA1	1.33e-07	285	203	12	34369648
Pubmed	Mitochondrial Raf1 Regulates Glutamine Catabolism.	HSP90B1 GALE MYO1A ACLY EPB41L3 TNS3 VDAC2 GPD2 ANXA5 LZTS1 SLC25A13 ACSL5	1.49e-07	288	203	12	38496616
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	KDM5B HSP90B1 ATRX ENPP2 ACTN1 GDI1 TRAPPC1 RYR3 U2AF1 EPS15L1 GAR1 SUPT5H DLG2 DLST HECTD1 MAP4K4 ADNP2 ARFGEF2 CLIC4 IDS EEF2 SCG3 ASB3 YLPM1 PRKDC	1.53e-07	1285	203	25	35914814
Pubmed	Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.	HSP90B1 POGLUT3 ACLY ACTN1 FABP3 DLST ALB TMED10 VDAC2 HSPD1 RARS1 ANXA5 CLIC4 SPATA20 MCOLN1 CYFIP2 EEF2 THY1 MTHFD1 SLC25A13	1.82e-07	859	203	20	31536960
Pubmed	Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation.	MYH1 MYH2 MYH4	1.96e-07	3	203	3	26059207
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	HSP90B1 ACLY CD109 ACTN1 RAB8A U2AF1 AP3D1 VDAC2 KIF2C HSPD1 KIF23 POLR1A RARS1 ARG1 EEF2 MTHFD1 SLC25A13 PRKDC IK SNRPD2 EPB41	2.04e-07	949	203	21	36574265
Pubmed	Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.	GALE ACLY U2AF1 GAR1 SUPT5H NUP210 TALDO1 VCAM1 VDAC2 KIF2C HSPD1 RARS1 EEF2 MTHFD1 PRKDC SNRPD2 EPB41 RAVER1	2.12e-07	707	203	18	19738201
Pubmed	Defining the Na+/H+ exchanger NHE1 interactome in triple-negative breast cancer cells.	HSP90B1 ACTN1 VDAC2 SFN HSPD1 ANXA5	2.83e-07	46	203	6	27751915
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	HSP90B1 ACLY ACTN1 AP1G1 TALDO1 AP3D1 VDAC2 SFN HSPD1 GPD2 RARS1 ANXA5 CYFIP2 EPG5 FSD1L EEF2 MTHFD1 PRKDC SNRPD2	3.17e-07	807	203	19	30575818
Pubmed	Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.	GALE GDI1 RAB8A DLST C5 TMED10 SIPA1L2 CPLANE1 TALDO1 SFN HSPD1 RARS1 ANXA5 EEF2 LZTS1 YLPM1 RBM5 SNRPD2	3.51e-07	732	203	18	34732716
Pubmed	Modulation of contractile protein gene expression in fetal murine crural muscles: emergence of muscle diversity.	MYH1 MYH2 MYH4 MYH8	3.60e-07	11	203	4	8136524
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	EPB41L3 RAB8A SIPA1L2 DOCK6 HECTD1 MAP4K4 MPP7 KIF2C CYFIP2 TRAPPC10 PLEKHA1 CEP295 PRKDC SNRPD2	4.31e-07	446	203	14	24255178
Pubmed	LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.	HSP90B1 ACTN1 ALB VDAC2 SFN HSPD1 RARS1 ARG1 MTHFD1 SLC25A13 PRKDC SNRPD2	5.78e-07	327	203	12	31409639
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	ACLY VPS13C ACTN1 NEB RAB8A FABP3 PEF1 ALB C5 SFN HSPD1 RARS1 ANXA5 CLIC4 TECTA CYFIP2 EEF2 SLC46A3 THY1 MTHFD1 PLEKHA1	6.19e-07	1016	203	21	19056867
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	HSP90B1 ACTN1 PGK2 STT3A CYFIP1 TMED10 MAP4K4 TALDO1 DHX29 AP3D1 VDAC2 SFN HSPD1 POLR1A RARS1 TOPBP1 CYFIP2 PRKDC SNRPD2	6.55e-07	847	203	19	35235311
Pubmed	Chemical Crosslinking Mass Spectrometry Analysis of Protein Conformations and Supercomplexes in Heart Tissue.	MYH1 MYH8 CFAP54 SRL DLST ALB CPLANE1 VDAC2 HSPD1 GFM2 EEF2 SLC25A13	6.57e-07	331	203	12	29199018
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	SYNRG HSP90B1 ATRX ACLY EPB41L3 EPS15L1 SIPA1L2 DHX29 AP3D1 VDAC2 HSPD1 KIF23 DPYSL4 IBTK MTHFD1 YLPM1 FAM169A NCOA7 PRKDC EPB41	6.75e-07	934	203	20	33916271
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	HSP90B1 POGLUT3 EPB41L3 STT3A MET NUP210 TMED10 VDAC2 HSPD1 RARS1 LIFR MTHFD1 LNPEP SLC25A13 UGGT2 PRKDC	7.43e-07	613	203	16	22268729
Pubmed	Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles.	MYH1 MYH2 MYH4 MYH8	7.73e-07	13	203	4	8404542
Pubmed	Evaluation of embryonic and perinatal myosin gene mutations and the etiology of congenital idiopathic clubfoot.	MYH1 MYH2 MYH8	7.80e-07	4	203	3	20357587
Pubmed	Three linked myosin heavy chain genes clustered within 370 kb of each other show independent transcriptional and post-transcriptional regulation during differentiation of a mouse muscle cell line.	MYH1 MYH4 MYH8	7.80e-07	4	203	3	1985022
Pubmed	Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling.	MYH1 MYH2 MYH4	7.80e-07	4	203	3	18417546
Pubmed	Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity.	MYH1 MYH2 MYH4	7.80e-07	4	203	3	10388558
Pubmed	A human YAC transgene rescues craniofacial and neural tube development in PDGFRalpha knockout mice and uncovers a role for PDGFRalpha in prenatal lung growth.	MYH1 MYH2 MYH4	7.80e-07	4	203	3	11023856
Pubmed	Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle.	MYH1 MYH2 MYH4	7.80e-07	4	203	3	11029314
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	HSP90B1 ACLY U2AF1L4 ACTN1 U2AF1 PEF1 CYFIP1 GAR1 AP1G1 HECTD1 AP3D1 VDAC2 SFN HSPD1 GPD2 RARS1 ANXA5 EEF2 MTHFD1 SLC25A13 PRKDC LSM2 IK SNRPD2 RAVER1	9.01e-07	1415	203	25	28515276
Pubmed	The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3.	HSP90B1 PDE6A ACLY EPB41L3 GDI1 ALB TALDO1 VDAC2 HSPD1 ANXA5 DPYSL4 EEF2 THY1 FAM169A EPB41	1.01e-06	552	203	15	36293380
Pubmed	LINKIN, a new transmembrane protein necessary for cell adhesion.	HSP90B1 U2AF1 MGAT2 NUP210 DLST TMED10 AP3D1 HSPD1 RARS1 EEF2 MTHFD1 SLC25A13 PRKDC SNRPD2	1.03e-06	480	203	14	25437307
Pubmed	Exploring an Alternative Cysteine-Reactive Chemistry to Enable Proteome-Wide PPI Analysis by Cross-Linking Mass Spectrometry.	DAB2IP ACTN1 EPB41L3 GDI1 DLG2 ALB AP3D1 VDAC2 HSPD1 RARS1 ARFGEF2 EEF2 SNRPD2	1.03e-06	411	203	13	36652389
Pubmed	Loss of Prox1 in striated muscle causes slow to fast skeletal muscle fiber conversion and dilated cardiomyopathy.	MYH1 MYH2 MYH4 ACTN1	1.08e-06	14	203	4	24938781
Pubmed	Distinct requirements for Gab1 in Met and EGF receptor signaling in vivo.	MYH1 MYH2 MET FLT1	1.08e-06	14	203	4	17881575
Pubmed	Defective excitation-contraction coupling is partially responsible for impaired contractility in hindlimb muscles of Stac3 knockout mice.	MYH1 MYH2 MYH4 MYH8	1.08e-06	14	203	4	27184118
Pubmed	Protein profiling of human pancreatic islets by two-dimensional gel electrophoresis and mass spectrometry.	HSP90B1 ALB VDAC2 HSPD1 ANXA5 EEF2	1.15e-06	58	203	6	15952740
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	HSP90B1 ACLY ACTN1 GDI1 SVEP1 U2AF1 DLST TALDO1 AP3D1 VDAC2 HSPD1 EEF2 MTHFD1 PRKDC LSM2 IK SNRPD2	1.17e-06	714	203	17	28302793
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MYH2 HSP90B1 CD109 TRAPPC1 STT3A NUP210 DLST TMED10 COG5 DHX29 AP3D1 VDAC2 HSPD1 GPD2 KIF23 ANXA5 VPS8 GFM2 LIFR EEF2 SLC25A13 TRAPPC10 PRKDC SNRPD2 RAVER1	1.24e-06	1440	203	25	30833792
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	HSP90B1 ACLY VPS13C GDI1 CYFIP1 DLST ALB TMED10 TALDO1 VDAC2 HSPD1 RARS1 ANXA5 ARG1 EEF2 MTHFD1 SLC25A13 PRKDC	1.32e-06	803	203	18	36517590
Pubmed	MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.	HSP90B1 ACLY INSR RAB8A PEF1 CYFIP1 ALB TALDO1 HSPD1 ANXA5 CLIC4 CYFIP2 EEF2 MTHFD1 SNRPD2	1.35e-06	565	203	15	20458337
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	HSP90B1 ERCC2 ACLY TRAPPC1 STT3A U2AF1 MGAT2 CYFIP1 NUP210 TMED10 HECTD1 VDAC2 SFN HSPD1 POLR1A RARS1 EEF2 MTHFD1 SLC25A13 MTR PRKDC IK SNRPD2	1.42e-06	1257	203	23	37317656
Pubmed	PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer.	C5 CYFIP2 PRKDC	1.94e-06	5	203	3	38691454
Pubmed	Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections.	MYH1 MYH2 MYH4	1.94e-06	5	203	3	30737693
Pubmed	TRIM37 Mediates Chemoresistance and Maintenance of Stemness in Pancreatic Cancer Cells via Ubiquitination of PTEN and Activation of the AKT-GSK-3β-β-Catenin Signaling Pathway.	MYH2 MYH4 HSP90B1 ACTN1 ALB TMED10 VDAC2 HSPD1 ANXA5 EEF2 PRKDC	2.04e-06	305	203	11	33194618
Pubmed	IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism.	MYH1 MYH2 MYH4 PPARGC1B	2.53e-06	17	203	4	22351927
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	TDRD15 MYH1 MYH2 MYH4 HSP90B1 MYH8 ACTN1 NEB MYO3A SFN HSPD1 RARS1 ARG1 EEF2 MTHFD1 SLC25A13 PRKDC SNRPD2	2.65e-06	844	203	18	25963833
Pubmed	Protein interaction screening for the ankyrin repeats and suppressor of cytokine signaling (SOCS) box (ASB) family identify Asb11 as a novel endoplasmic reticulum resident ubiquitin ligase.	ACLY EPB41L3 AP1G1 TMED10 HSPD1 ANXA5 SLC25A13 ASB3 PRKDC	2.73e-06	198	203	9	24337577
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	HSP90B1 ACLY ACTN1 STT3A AP1G1 ALB KIF2C HSPD1 RARS1 GFM2 EEF2 MTHFD1 RAVER1	2.87e-06	451	203	13	36168627
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ATRX U2AF1L4 EPB41L3 U2AF1 EPS15L1 PEF1 CYFIP1 GAR1 VDAC2 HSPD1 KIF23 TOPBP1 CYFIP2 EEF2 YLPM1 PRKDC IK SNRPD2 EPB41	3.72e-06	954	203	19	36373674
Pubmed	The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2.	GDI1 RAB8A DLST GPD2 GRB10 DPYSL4 CYFIP2 LNPEP GYG1 SLC25A13 LSM2	3.74e-06	325	203	11	36168628
Pubmed	A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre.	MYH1 MYH2 MYH4	3.87e-06	6	203	3	17559643
Pubmed	A hypoplastic model of skeletal muscle development displaying reduced foetal myoblast cell numbers, increased oxidative myofibres and improved specific tension capacity.	MYH1 MYH2 MYH4	3.87e-06	6	203	3	20417199
Pubmed	Type 3 and type 1 ryanodine receptors are localized in triads of the same mammalian skeletal muscle fibers.	MYH2 RYR3 CACNA1S	3.87e-06	6	203	3	10444070
Pubmed	Analysis of Ku70 S155 Phospho-Specific BioID2 Interactome Identifies Ku Association with TRIP12 in Response to DNA Damage.	HSP90B1 ALB VDAC2 HSPD1 ARG1 EEF2 MTHFD1 PRKDC	4.07e-06	156	203	8	37108203
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	HSP90B1 ACLY EPB41L3 STT3A U2AF1 AP1G1 HSPD1 GPD2 RARS1 CLIC4 UBLCP1 EEF2 MTHFD1 SLC25A13 FAM169A PRKDC LSM2 EPB41	4.57e-06	878	203	18	37223481
Pubmed	Discovery and refinement of loci associated with lipid levels.	INSR MET AFF1 DOCK6 ANGPTL1 MSL2 TYW1B CSNK1G3 RBM5	4.58e-06	211	203	9	24097068
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	EPHB3 STT3A RAB8A MET C5 TMED10 DOCK6 GPD2 SEMA4B PLEKHG4 ANXA5 ARFGEF2 IFITM1 SPG11 ENTPD4 TGFBR1 MTHFD1 RBM5 UGGT2 PRKDC	4.64e-06	1061	203	20	33845483
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	SYNRG STT3A TMED10 HECTD1 DHX29 AP3D1 VDAC2 HSPD1 IBTK MTHFD1 VWA5A SLC25A13 PRKDC IK	4.67e-06	547	203	14	37267103
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SYNRG ACLY ACTN1 EPS15L1 CYFIP1 MAP4K4 VDAC2 KIF23 RARS1 SLC25A13 YLPM1 PRKDC IK EPB41	4.87e-06	549	203	14	38280479
Pubmed	Novel, gel-free proteomics approach identifies RNF5 and JAMP as modulators of GPCR stability.	HSP90B1 NUP210 VDAC2 HSPD1 EEF2 MTHFD1 SLC25A13 PRKDC	4.90e-06	160	203	8	23798571
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	HSP90B1 GALE STT3A RAB8A U2AF1 DLST VDAC2 HSPD1 RARS1 GFM2 EEF2 SLC25A13 PRKDC LSM2 SNRPD2 ACSL5	4.97e-06	711	203	16	33022573
Pubmed	Repression of rRNA transcription by PARIS contributes to Parkinson's disease.	HSP90B1 ACLY ACTN1 U2AF1 CYFIP1 AP1G1 EEF2 MTHFD1 SLC25A13 PRKDC	5.05e-06	272	203	10	25315684
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	ACLY ACTN1 PGK2 FABP3 PEF1 CYFIP1 ALB C5 PZP TALDO1 VCAM1 SFN TRHDE ANXA5 CYFIP2 LIFR EEF2 THY1 MTHFD1 LYN	5.26e-06	1070	203	20	23533145
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	HSP90B1 ACLY ACTN1 U2AF1 CYFIP1 AP1G1 NUP210 HECTD1 AP3D1 HSPD1 RARS1 EEF2 MTHFD1 SLC25A13 PRKDC	5.90e-06	638	203	15	33239621
Pubmed	Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex.	HSP90B1 ACTN1 ALB EEF2	6.24e-06	21	203	4	30503554
Pubmed	Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant.	ACTN1 CYFIP1 DLST ALB AP3D1 TNS3 SFN HSPD1 RARS1 EEF2 MTHFD1 PRKDC SNRPD2	6.72e-06	488	203	13	31324722
Pubmed	Physiological and pathophysiological characteristics of ataxin-3 isoforms.	HSP90B1 ACLY ACTN1 CYFIP1 DLST HSPD1 RARS1 EEF2 PRKDC SNRPD2	6.72e-06	281	203	10	30455355
Pubmed	Functions of adaptor protein (AP)-3 and AP-1 in tyrosinase sorting from endosomes to melanosomes.	SYNRG AP1G1 AP3D1	6.74e-06	7	203	3	16162817
Interaction	RICTOR interactions	HSP90B1 ACLY ACTN1 EPB41L3 TRAPPC13 MET CYFIP1 ALB TMED10 TALDO1 DHX29 VDAC2 SFN HSPD1 GPD2 KIF23 RARS1 ANXA5 ARFGEF2 GRB10 ARG1 AGBL4 EEF2 MTHFD1 ASB3 PRKDC IK LYN EPB41	4.79e-10	759	200	29	int:RICTOR
Interaction	C11orf52 interactions	DAB2IP INSR EPB41L3 STT3A MET CYFIP1 MAP4K4 MPP7 DOCK9 LNPEP SLC25A13 PLEKHA1 LYN EPB41	2.92e-06	311	200	14	int:C11orf52
Interaction	KCNA3 interactions	HSP90B1 ACLY EPB41L3 GDI1 STT3A EPS15L1 CYFIP1 GAR1 MAP4K4 DHX29 AP3D1 MPP7 VDAC2 KIF2C HSPD1 GPD2 RARS1 GRB10 EEF2 MTHFD1 SLC25A13 PLEKHA1 PRKDC EPB41	6.16e-06	871	200	24	int:KCNA3
Interaction	CDC73 interactions	HSP90B1 ACTN1 RAB8A SUPT5H ALB HECTD1 AP3D1 SFN HSPD1 RARS1 ARFGEF2 GRB10 EEF2 MTHFD1 PRKDC	7.69e-06	386	200	15	int:CDC73
Interaction	TRAPPC3 interactions	INSR TRAPPC1 TRAPPC13 CYFIP1 VCAM1 IFITM1 TRAPPC10	1.05e-05	76	200	7	int:TRAPPC3
Interaction	LAMTOR1 interactions	SYNRG VPS13C INSR AP1G1 MAP4K4 AP3D1 MPP7 VDAC2 VPS8 ARFGEF2 IFITM1 SPG11 PIKFYVE BBS7 LNPEP CSNK1G3 SLC25A13 MTR NCOA7 PLEKHA1 LYN	1.09e-05	722	200	21	int:LAMTOR1
Interaction	MECP2 interactions	KDM5B HSP90B1 ATRX EPB41L3 STT3A U2AF1 GAR1 SUPT5H PCDH15 DLST ALB SIPA1L2 PZP DOCK6 MAP4K4 AP3D1 VDAC2 HSPD1 GPD2 ANXA5 DPYSL4 ARG1 EEF2 SCG3 SLC25A13 YLPM1 RBM5 PRKDC IK SNRPD2	1.10e-05	1287	200	30	int:MECP2
Interaction	CTSS interactions	HSP90B1 POGLUT3 ACTN1 STT3A NUP210 TMED10 SLC25A13 UGGT2 PRKDC	1.48e-05	145	200	9	int:CTSS
Interaction	HYOU1 interactions	HSP90B1 INSR CD109 MET EPS15L1 PXMP2 DLST TMED10 DOCK6 FLT1 WDFY4 EEF2 LNPEP	1.80e-05	317	200	13	int:HYOU1
Interaction	GSK3B interactions	SYNRG HSP90B1 GALE ACLY ACTN1 EPB41L3 MET U2AF1 CYFIP1 ALB SIPA1L2 HECTD1 TNS3 HSPD1 GPD2 RARS1 SLA ARG1 IBTK EEF2 MTHFD1 SLC25A13 PRKDC	1.82e-05	868	200	23	int:GSK3B
Interaction	RAC1 interactions	DAB2IP EPB41L3 STT3A RAB8A MET CYFIP1 COG5 DOCK6 MAP4K4 TALDO1 VCAM1 TNS3 MPP7 PLEKHG4 DOCK9 ANXA5 UBE3B CYFIP2 PIKFYVE TGFBR1 EEF2 LNPEP CSNK1G3 FAM169A PLEKHA1 LYN	2.01e-05	1063	200	26	int:RAC1
Interaction	RSPH6A interactions	MYH1 MYH2 MYH4 MYH8 NEB	2.02e-05	34	200	5	int:RSPH6A
Interaction	FBXO22 interactions	NEB EPB41L3 RYR3 CYFIP1 GAR1 MAP4K4 AP3D1 KIF2C DPYD FLT1 POLR1A DOCK9 SPG11 RGS12 MTHFD1 SLC25A13 IK	2.93e-05	540	200	17	int:FBXO22
Interaction	TEC interactions	EPHB3 MET CYFIP1 FLT1 POLR1A CYFIP2 LYN	3.18e-05	90	200	7	int:TEC
Interaction	CALU interactions	HSP90B1 POGLUT3 MET NUP210 THG1L PXMP2 TMED10 VDAC2 KIF23 IFITM1 RNASEL MTR UGGT2	3.30e-05	336	200	13	int:CALU
Interaction	MAPT interactions	SYNRG HSP90B1 ACLY ACTN1 EPB41L3 GDI1 GAR1 MAP4K4 DHX29 VDAC2 SFN HSPD1 GPD2 ANXA5 DPYSL4 UBLCP1 CYFIP2 ARG1 FSD1L EEF2 THY1 MTHFD1 SCG3 SLC25A13 SNRPD2 EPB41	4.78e-05	1119	200	26	int:MAPT
Interaction	CFTR interactions	MYH1 MYH2 MYH4 HSP90B1 POGLUT3 MYH8 MYO1A ACLY ACTN1 GDI1 RYR3 SLC9B1 CYFIP1 NUP210 DLST ALB PZP AP3D1 TNS3 VDAC2 SFN HSPD1 RARS1 ANXA5 AGBL4 EEF2 MTHFD1 SLC25A13 UBR3 PRKDC SNRPD2	6.07e-05	1480	200	31	int:CFTR
Interaction	LOXL2 interactions	HSP90B1 ACTN1 ALB VDAC2 SFN HSPD1 RARS1 IDS ARG1 MTHFD1 SLC25A13 PRKDC IK SNRPD2	6.39e-05	410	200	14	int:LOXL2
Interaction	RAB1A interactions	ACLY VPS13C GDI1 RAB8A TRAPPC13 AP1G1 PXMP2 DLST TMED10 COG5 VDAC2 HSPD1 KIF23 RARS1 EEF2	6.48e-05	464	200	15	int:RAB1A
Interaction	ABTB2 interactions	MYH1 MYH2 MYH4 MYH8 NEB PGK2 HSPD1	6.68e-05	101	200	7	int:ABTB2
Interaction	TPM1 interactions	MYH1 MYH2 MYH4 HSP90B1 MYH8 ACTN1 NEB DLST WDFY4 TGFBR1 EPB41	6.71e-05	263	200	11	int:TPM1
Interaction	CFD interactions	HSP90B1 POGLUT3 ACLY CD109 U2AF1L4 EPB41L3 STT3A RAB8A MGAT2 AP1G1 DLST ALB TMED10 MAP4K4 AP3D1 VDAC2 HSPD1 GPD2 SEMA4B GFM2 CYFIP2 EEF2 LNPEP ASXL3 UGGT2 LSM2 SNRPD2 ACSL5 RAVER1	7.90e-05	1360	200	29	int:CFD
Interaction	FBXO6 interactions	HSP90B1 POGLUT3 CD109 EPB41L3 STT3A MET NUP210 ALB TMED10 VDAC2 TRHDE HSPD1 RARS1 LIFR MTHFD1 LNPEP SLC25A13 UGGT2 PRKDC	1.01e-04	717	200	19	int:FBXO6
Interaction	LYN interactions	DAB2IP EPHB3 HSP90B1 EPB41L3 MET CYFIP1 MAP4K4 MPP7 KIF23 POLR1A CYFIP2 FSD1L LNPEP CSNK1G3 SCG3 PLEKHA1 PRKDC LYN EPB41	1.07e-04	720	200	19	int:LYN
Interaction	RBM39 interactions	HSP90B1 ATRX ACLY ACTN1 GDI1 SVEP1 U2AF1 DLST POLK HECTD1 TALDO1 AP3D1 VDAC2 SFN HSPD1 PLEKHG4 GRB10 EEF2 MTHFD1 YLPM1 PRKDC LSM2 IK SNRPD2	1.09e-04	1042	200	24	int:RBM39
Interaction	PCDH7 interactions	HSP90B1 DCDC1 ACTN1 MET TALDO1 SFN HSPD1 ANXA5 IFITM1 EEF2 LYN	1.13e-04	279	200	11	int:PCDH7
Interaction	SNAI1 interactions	ACLY EPB41L3 STT3A U2AF1 GAR1 ALB HECTD1 VDAC2 HSPD1 RARS1 EEF2 MTHFD1 SLC25A13 RBM5 PRKDC SNRPD2	1.17e-04	546	200	16	int:SNAI1
Interaction	KCTD13 interactions	HSP90B1 ACLY ACTN1 EPB41L3 GDI1 TRAPPC1 U2AF1 EPS15L1 CYFIP1 AP1G1 DLG2 DLST ALB SIPA1L2 DHX29 AP3D1 VDAC2 HSPD1 GPD2 ARFGEF2 DPYSL4 CYFIP2 AGBL4 EEF2 THY1 LZTS1 MTHFD1 TRAPPC10 SNRPD2	1.21e-04	1394	200	29	int:KCTD13
Interaction	LATS1 interactions	MYH1 MYH2 MYH4 MYH8 NEB RAB8A ALB SIPA1L2 MAP4K4 VDAC2 SFN KIF23 SLC25A13 PLEKHA1	1.34e-04	440	200	14	int:LATS1
Interaction	RHOF interactions	ACTN1 EPB41L3 STT3A RAB8A CYFIP1 GAR1 MAP4K4 TNS3 MPP7 DOCK9 ARFGEF2 PIKFYVE LNPEP FAM169A PLEKHA1 PRKDC LYN EPB41	1.38e-04	673	200	18	int:RHOF
Interaction	CTSL interactions	HSP90B1 ACTN1 DLST ALB VDAC2 KIF23 RARS1 CLIC4 SLC25A13 PRKDC	1.48e-04	240	200	10	int:CTSL
Interaction	SAR1B interactions	HSP90B1 ACLY ACTN1 GDI1 PXMP2 TMED10 KIF2C HSPD1 CLIC4 EEF2 MTHFD1 PRKDC	1.53e-04	339	200	12	int:SAR1B
Interaction	RIPK4 interactions	HSP90B1 ACLY EPB41L3 VDAC2 HSPD1 ANXA5 FSD1L MTHFD1 BBS7 VWA5A SLC25A13 ASB3 MTR PRKDC	1.55e-04	446	200	14	int:RIPK4
Interaction	CTNNB1 interactions	HSP90B1 ACLY ACTN1 MET CYFIP1 SIPA1L2 HECTD1 VDAC2 SFN HSPD1 FLT1 KIF23 RARS1 ARFGEF2 GRB10 CYFIP2 TGFBR1 EEF2 MTHFD1 SLC25A13 PRKDC LYN SNRPD2	1.78e-04	1009	200	23	int:CTNNB1
Interaction	RAB35 interactions	DAB2IP VPS13C EPB41L3 GDI1 CYFIP1 MAP4K4 MPP7 DOCK9 ARFGEF2 LNPEP CSNK1G3 SLC25A13 NCOA7 PLEKHA1 LYN EPB41	2.02e-04	573	200	16	int:RAB35
Cytoband	2q11.2-q12	MAP4K4 AFF3	1.95e-05	2	203	2	2q11.2-q12
Cytoband	17p13.1	MYH1 MYH2 MYH4 MYH8 TRAPPC1	1.88e-04	118	203	5	17p13.1
Cytoband	5q33.3	THG1L UBLCP1 CYFIP2	5.46e-04	36	203	3	5q33.3
Cytoband	1p33-p32	FABP3 EPB41	6.86e-04	9	203	2	1p33-p32
Cytoband	14q24.3	DLST TMED10 RGS6 YLPM1	7.97e-04	93	203	4	14q24.3
GeneFamily	Myosin heavy chains	MYH1 MYH2 MYH4 MYH8	4.92e-06	15	144	4	1098
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	CD109 C5 PZP	4.01e-05	9	144	3	1234
GeneFamily	Trafficking protein particle complex	TRAPPC1 TRAPPC13 TRAPPC10	1.69e-04	14	144	3	772
GeneFamily	Erythrocyte membrane protein band 4.1\|FERM domain containing	EPB41L3 EPB41	3.74e-04	4	144	2	951
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF1 AFF3	3.74e-04	4	144	2	1145
GeneFamily	EF-hand domain containing	RYR3 EPS15L1 PEF1 CAPS2 GPD2 EFHC2 PPP3R2 SLC25A13	3.75e-04	219	144	8	863
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF1 AFF3	2.19e-03	9	144	2	1280
GeneFamily	Mannosyl-glycoprotein N-acetylglucosaminyltransferases	MGAT4D MGAT2	2.19e-03	9	144	2	435
Coexpression	HUMMERICH_BENIGN_SKIN_TUMOR_DN	MYH1 MYH2 MYH4 MYH8 AFF1 ALB	7.10e-09	20	203	6	M1123
Coexpression	HUMMERICH_BENIGN_SKIN_TUMOR_DN	MYH1 MYH2 MYH4 MYH8 AFF1 ALB	9.87e-09	21	203	6	MM1102
Coexpression	GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	INSR ACTN1 GAR1 PZP MPP7 SELL AFF3 VWA5A RAVER2 PLEKHA1	2.84e-07	150	203	10	M9139
Coexpression	ONKEN_UVEAL_MELANOMA_UP	ACLY GDI1 FABP3 TRAPPC13 MET MGAT2 DLST CHST3 DOCK9 ARFGEF2 IFITM1 CLIC4 SPATA20 IFITM2 LZTS1 SLC25A13 MTR TRAPPC10 UGGT2 PRKDC LYN	9.84e-07	790	203	21	M12490
Coexpression	GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP	SYNRG HSP90B1 ACTN1 MET AFF1 GPD2 WDFY4 CYFIP2 METTL6 NCOA7	3.73e-06	199	203	10	M6040
Coexpression	PEREZ_TP53_TARGETS	DAB2IP EPHB3 VPS13C MYT1 INSR EPB41L3 AFF1 NTN1 SIPA1L2 ELMOD1 ACAP3 CHST3 POLR1A AFF3 ARFGEF2 DPYSL4 GLB1L2 LHX6 CYFIP2 MSL2 LIFR EEF2 LZTS1 MEGF10 EPB41	7.10e-06	1201	203	25	M4391
Coexpression	GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP	VPS13C INSR ACTN1 MAP4K4 SELL SEMA4B TGFBR1 MTR PLEKHA1	8.30e-06	172	203	9	M2945
Coexpression	HUMMERICH_MALIGNANT_SKIN_TUMOR_DN	MYH2 MYH8 AFF1 ALB	1.54e-05	20	203	4	M1127
Coexpression	HUMMERICH_MALIGNANT_SKIN_TUMOR_DN	MYH2 MYH8 AFF1 ALB	1.89e-05	21	203	4	MM1103
Coexpression	GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN	KDM5B DLST SELL VPS8 IFITM1 IFITM2 CYFIP2 PIKFYVE LYN	2.45e-05	197	203	9	M3255
Coexpression	GSE39556_CD8A_DC_VS_NK_CELL_UP	GALE ACTN1 STT3A CYFIP1 MAP4K4 KIF2C KIF23 GRB10 MTHFD1	2.76e-05	200	203	9	M9406
Coexpression	GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	IFT140 RYR3 VCAM1 CACNA1S SPG11 ENTPD4 RGS12 CYFIP2 RBM5	2.76e-05	200	203	9	M6477
Coexpression	GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP	SYNRG INSR GDI1 GPD2 AFF3 ARFGEF2 ANGPTL1 UBLCP1 GYG1	2.76e-05	200	203	9	M7831
Coexpression	GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP	HSP90B1 STT3A SFN ANXA5 ADNP2 IDS MTHFD1 CSNK1G3 PRKDC	2.76e-05	200	203	9	M5777
Coexpression	GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP	KDM5B INSR ACTN1 GAR1 SELL POLR1A ANGPTL1 PLEKHA1	4.02e-05	162	203	8	M7005
Coexpression	LAKE_ADULT_KIDNEY_C9_THIN_ASCENDING_LIMB	HSP90B1 VPS13C MET HECTD1 HSPD1 ANXA5 IFITM2 EEF2 NCOA7 PLEKHA1	4.90e-05	268	203	10	M39228
Coexpression	GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP	GAR1 HSPD1 POLR1A RARS1 IFITM1 IFITM2 PPP2R5B TRAPPC10	6.14e-05	172	203	8	M2963
Coexpression	GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN	SYNRG ACLY TRAPPC1 NUP210 DHX29 IDS UBLCP1 NCOA7	7.51e-05	177	203	8	M6703
Coexpression	GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP	ACTN1 NUP210 POLR1A TOPBP1 WDFY4 CYFIP2 MTHFD1 NCOA7	9.84e-05	184	203	8	M6756
Coexpression	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	NUP210 PXMP2 KIF2C KIF23 IFITM1 IFITM2 CYFIP2 MTHFD1	1.06e-04	186	203	8	M19867
Coexpression	BERENJENO_TRANSFORMED_BY_RHOA_UP	ACTN1 GAR1 TALDO1 KIF2C HSPD1 GPD2 KIF23 RARS1 TOPBP1 THY1 PLEKHA1 LSM2 SNRPD2 ACSL5	1.07e-04	550	203	14	M16189
Coexpression	BERENJENO_TRANSFORMED_BY_RHOA_UP	ACTN1 GAR1 TALDO1 KIF2C HSPD1 GPD2 KIF23 RARS1 TOPBP1 THY1 PLEKHA1 LSM2 SNRPD2 ACSL5	1.57e-04	571	203	14	MM1100
Coexpression	GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_DN	SVEP1 AFF1 DPYD KIF23 ANXA5 AFF3 CLIC4 SLC17A1	1.69e-04	199	203	8	M9423
Coexpression	GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP	EPB41L3 GDI1 NUP210 MPP7 CACNA1S SPG11 ANGPTL1 CYFIP2	1.69e-04	199	203	8	M6443
Coexpression	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN	ACTN1 TMED10 PZP VDAC2 ANXA5 CLIC4 EEF2 SNRPD2	1.69e-04	199	203	8	M5240
Coexpression	GSE15767_MED_VS_SCS_MAC_LN_UP	EPB41L3 SRL SELL KIF23 NRAP ANXA5 IFITM2 LYN	1.75e-04	200	203	8	M3584
Coexpression	GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP	MYH1 MYH4 GAR1 NTN1 CLIC4 ARG1 EEF2 C2orf80	1.75e-04	200	203	8	M8203
Coexpression	GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	PDE6A RAB8A CFAP54 HECTD1 GPD2 CLIC4 MSL2 RNASEL	1.75e-04	200	203	8	M7198
Coexpression	GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_UP	PXMP2 GRB10 UBLCP1 PIKFYVE MTHFD1 MTR TRAPPC10 EPB41	1.75e-04	200	203	8	M7516
Coexpression	GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN	POLK DOCK6 TOPBP1 IDS ANGPTL1 IBTK TRAPPC10 LYN	1.75e-04	200	203	8	M7372
Coexpression	GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN	DAB2IP KIF23 ENTPD4 AGBL3 LIFR PPARGC1B TRAPPC10 ACSL5	1.75e-04	200	203	8	M7780
Coexpression	GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	ACTN1 GDI1 TALDO1 DHX29 ANXA5 SLA THY1 VWA5A	1.75e-04	200	203	8	M6248
Coexpression	GSE17721_4_VS_24H_CPG_BMDC_DN	ENPP2 GDI1 MGAT2 CYFIP1 ADNP2 SLA EPB41 ACSL5	1.75e-04	200	203	8	M4131
Coexpression	LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR	HSP90B1 ENPP2 DPYD FLT1 DOCK9 CLIC4 IFITM2	1.89e-04	152	203	7	M39243
Coexpression	PEREZ_TP53_AND_TP63_TARGETS	EPHB3 INSR EPB41L3 NTN1 SIPA1L2 ELMOD1 DPYSL4 EPB41	2.21e-04	207	203	8	M14566
ToppCell	COVID-19-B_cells-Activated_B_cells\|COVID-19 / group, cell type (main and fine annotations)	MYT1 NUP210 PARP15 SELL AFF3 WDFY4 ANGPTL1 CYFIP2 SETBP1 LYN	9.35e-09	177	203	10	653bb62a3744d4024ab3186ee01d410ed62832a6
ToppCell	343B-Endothelial_cells-Endothelial-A_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ACTN1 EPB41L3 MET GMPR VCAM1 HSPD1 IFITM1 LHX6 LIFR NCOA7	2.59e-08	197	203	10	ec92d60f802c9d4bdf9877bed5c0a91a5a5ed5d0
ToppCell	343B-Endothelial_cells-Endothelial-A_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ACTN1 EPB41L3 MET GMPR VCAM1 HSPD1 IFITM1 LHX6 LIFR NCOA7	2.59e-08	197	203	10	7bec9c1bc8851064eb229324493b47a31201c83c
ToppCell	Control_saline-Endothelial-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	CD109 SIPA1L2 DOCK6 MAP4K4 FLT1 DOCK9 CLIC4 ENTPD4 LIFR PLEKHA1	2.99e-08	200	203	10	e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCell	Control_saline-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	CD109 SIPA1L2 DOCK6 MAP4K4 FLT1 DOCK9 CLIC4 ENTPD4 LIFR PLEKHA1	2.99e-08	200	203	10	3372c488a39fe812fa94e4f0564594186fea3db5
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH2 MYH4 NEB FABP3 PXMP2 SRL GMPR NRAP	1.11e-07	174	203	9	4a6e04b4f12b87c15fa1409989cbe32c43736369
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH4 NEB FABP3 SRL GMPR NRAP GYG1 SEL1L2	1.35e-07	178	203	9	69f68eeab11b088fcb1f963c92eff0f1cd0e711a
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH2 MYH4 NEB FABP3 PXMP2 SRL GMPR NRAP GYG1	1.49e-07	180	203	9	cea62fc006d68c3815c88bf17ec2617d7e41c3d2
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH1 MYH4 DCDC1 CFAP54 DLG2 ELMOD1 TNS3 TRHDE CLIC4	1.56e-07	181	203	9	6956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCell	Control-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	MAP4K4 TNS3 PARP15 AFF3 CLIC4 WDFY4 PIKFYVE SETBP1 LYN	2.06e-07	187	203	9	4e64be635f445276e71f2937f33f041c3a4204ab
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH4 NEB FABP3 PXMP2 SRL GMPR NRAP GYG1	2.25e-07	189	203	9	d2b008f98739c6af7ee63b643011a240db20e4d8
ToppCell	5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ENPP2 ACTN1 EPB41L3 RYR3 FLT1 IFITM1 IFITM2 LHX6 LIFR	2.57e-07	192	203	9	eafead22bba48ac5ee568faa8946c444445c1034
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PARP15 AFF3 WDFY4 ANGPTL1 PIKFYVE CSNK1G3 SETBP1 TRAPPC10 LYN	2.69e-07	193	203	9	bbea475d2c4c7b29674ff302529f8f83dd666dcb
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	SYNRG KDM5B ATRX AFF1 CPLANE1 HECTD1 CSNK1G3 TRAPPC10 PRKDC	2.69e-07	193	203	9	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VPS13C MAP4K4 PARP15 AFF3 WDFY4 ANGPTL1 PIKFYVE SETBP1 LYN	2.81e-07	194	203	9	ff661419b697aef51a53fdeac8d37d870d65f491
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX ACLY VPS13C EPB41L3 GMPR GPD2 GRIN2C CYFIP2 SCG3	2.93e-07	195	203	9	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX ACLY VPS13C EPB41L3 GMPR GPD2 GRIN2C CYFIP2 SCG3	2.93e-07	195	203	9	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRAPPC1 PARP15 SELL AFF3 DPYSL4 WDFY4 CYFIP2 WSCD2 LYN	3.20e-07	197	203	9	e4b4fa219322b3250b482f8e242f41e8b05485db
ToppCell	distal-1-Endothelial-Bronchial_Vessel_1\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ENPP2 INSR VCAM1 FLT1 GRB10 IFITM1 LHX6 LIFR NCOA7	3.33e-07	198	203	9	5cd81fe1a21c0e1a7f0d5a62ddf8e422b05aedc7
ToppCell	5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ENPP2 ACTN1 EPB41L3 RYR3 VCAM1 FLT1 IFITM2 LHX6 LIFR	3.48e-07	199	203	9	07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ATRX ENPP2 CD109 SIPA1L2 DOCK6 FLT1 DOCK9 LHX6 LIFR	3.63e-07	200	203	9	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYH2 NEB PARP15 SEMA4B AFF3 WDFY4 ANGPTL1 SETBP1	6.13e-07	156	203	8	d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DCDC1 MET KIRREL3 MYO3A CFAP54 VCAM1 AGBL4 WSCD2	1.07e-06	168	203	8	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	Control-B_cells-Activated_B_cells\|Control / group, cell type (main and fine annotations)	PARP15 SELL AFF3 WDFY4 ANGPTL1 CYFIP2 SETBP1 LYN	1.07e-06	168	203	8	a7159a35fe37f8c241cf8d391debe271e0698105
ToppCell	facs-Lung-nan-3m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1A KIRREL3 CYFIP1 VCAM1 KIF2C NRAP LHX6 ENTPD4	1.17e-06	170	203	8	67d7e1da3ebd2d14cb2e67799e94d655027ed5c4
ToppCell	facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1A KIRREL3 CYFIP1 VCAM1 KIF2C NRAP LHX6 ENTPD4	1.17e-06	170	203	8	8e1f757ed62218c0fb6525f49d142dd2cd29acf9
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DAB2IP ACTN1 MYO3A SRL ANKRD62 GRB10 RGS6 LZTS1	1.40e-06	174	203	8	015d3742d3d79a57413a333f00ef2d380a9848dd
ToppCell	356C-Fibroblasts-Fibroblast-E-\|356C / Donor, Lineage, Cell class and subclass (all cells)	POGLUT3 PDE6A NEB SVEP1 NTN1 CCDC160 ANGPTL1 THY1	1.66e-06	178	203	8	a493a277d175e5e153410a745b26ebe2e0839ea0
ToppCell	356C-Fibroblasts-Fibroblast-E\|356C / Donor, Lineage, Cell class and subclass (all cells)	POGLUT3 PDE6A NEB SVEP1 NTN1 CCDC160 ANGPTL1 THY1	1.66e-06	178	203	8	371218babddfd3d8a7bb82a46ce65327ee3fcf12
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RYR3 PZP SELL IFITM2 SLA ARG1 VWA5A LYN	1.66e-06	178	203	8	af9bcee71fb44a6342d4b92bba5b8ddfeeaa24b2
ToppCell	COVID-19-kidney-Stressed_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	INSR CD109 DOCK6 HSPD1 FLT1 GRB10 CLIC4 NCOA7	1.73e-06	179	203	8	754f69bac7a1d5137f5141f6193285ccbfe361cb
ToppCell	3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ENPP2 INSR FLT1 DOCK9 GRB10 IFITM1 IFITM2 LIFR	1.80e-06	180	203	8	efc4c5a4dea456527526bbfd88cf70d803893671
ToppCell	Children_(3_yrs)-Immune-B_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NUP210 PARP15 SELL SEMA4B AFF3 WDFY4 CYFIP2 SETBP1	1.80e-06	180	203	8	40a12eb852373ae3d7c8d9bca376b0ae99f724b3
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NUP210 MAP4K4 PARP15 SELL AFF3 WDFY4 CYFIP2 SETBP1	1.88e-06	181	203	8	8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH4 NEB FABP3 PXMP2 SRL CACNA1S NRAP	1.95e-06	182	203	8	edfc598b7199ca1d8a399b264ab863c299b1eede
ToppCell	3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ENPP2 FLT1 DOCK9 GRB10 IFITM1 IFITM2 LIFR THY1	2.04e-06	183	203	8	858682df5592c6856487487a7baabd6e60e63a38
ToppCell	3'-Adult-SmallIntestine-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ENPP2 FLT1 DOCK9 GRB10 IFITM1 IFITM2 LIFR THY1	2.04e-06	183	203	8	f8212bf8a8b8312434ae030261c558c147f61747
ToppCell	343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	FABP3 CYFIP1 THG1L PXMP2 CLIC4 EPG5 METTL6 BBS7	2.12e-06	184	203	8	2c2125b8030af83f7a6d59a7102d4de8e0ac1988
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH4 NEB FABP3 SRL GMPR NRAP GYG1	2.21e-06	185	203	8	9245c322aae8bb9065d50dada198a5ee143a3444
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HSP90B1 INSR CD109 SIPA1L2 DOCK6 FLT1 GRB10 CLIC4	2.21e-06	185	203	8	673308ca0514a4d3629d61fe91e9d8fb31b72166
ToppCell	Children_(3_yrs)-Immune-B_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NUP210 PARP15 SELL AFF3 WDFY4 ANGPTL1 CYFIP2 SETBP1	2.30e-06	186	203	8	aa576748921a318798b911a611f05319b95e8d5e
ToppCell	COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	MET DOCK6 VCAM1 FLT1 DOCK9 WNT9B LHX6 LIFR	2.39e-06	187	203	8	2d20193a6cacdfa4877457c97b0077408942186c
ToppCell	IPF-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	MAP4K4 TNS3 PARP15 AFF3 WDFY4 PIKFYVE SETBP1 LYN	2.39e-06	187	203	8	af1327559f7e01bec070881cae52834917c3da65
ToppCell	COVID-19-lung-Vein_EC\|lung / Disease (COVID-19 only), tissue and cell type	CD109 CC2D2B DOCK6 VCAM1 FLT1 DOCK9 LHX6 LIFR	2.49e-06	188	203	8	d582b76fc2faac526c9bf97503041129e1a6a211
ToppCell	COVID-19-kidney-VWF+PLVAP+VCAM1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	INSR RYR3 VCAM1 FLT1 WNT9B GRB10 LHX6 NCOA7	2.59e-06	189	203	8	c121817ddad164e9cfe382c43d0cbc9215508d02
ToppCell	facs-Brain_Myeloid-Striatum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STT3A CYFIP1 SEMA4B SLA GFM2 TGFBR1 LIFR LYN	2.59e-06	189	203	8	6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736
ToppCell	facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STT3A CYFIP1 SEMA4B SLA GFM2 TGFBR1 LIFR LYN	2.59e-06	189	203	8	875df61ee48baa5142ba4d2427bdec1c53e5a828
ToppCell	facs-Brain_Myeloid-Striatum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STT3A CYFIP1 SEMA4B SLA GFM2 TGFBR1 LIFR LYN	2.59e-06	189	203	8	3ae479ec7e00c57127cbe51a398329b10ca9848c
ToppCell	facs-Brain_Myeloid-Striatum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STT3A CYFIP1 SEMA4B SLA GFM2 TGFBR1 LIFR LYN	2.59e-06	189	203	8	97ef5215d841ff366a3e3682cd9bd04100cbfde0
ToppCell	droplet-Marrow-nan-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSP90B1 STT3A MGAT2 GAR1 DLG2 GMPR VCAM1 ENTPD4	2.69e-06	190	203	8	240923769fef18eaf73d2efa3d5f745f5533b0ce
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ENPP2 CD109 SIPA1L2 DOCK6 FLT1 DOCK9 AFF3 RGS6	2.69e-06	190	203	8	a3c6eec6df052105ab78b7e3c78f94218d5912eb
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	MAP4K4 TNS3 PARP15 AFF3 WDFY4 PIKFYVE SETBP1 LYN	2.69e-06	190	203	8	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	COVID-19-lung-Vein_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CD109 ACTN1 DOCK6 VCAM1 FLT1 DOCK9 LHX6 LIFR	2.69e-06	190	203	8	1caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCell	droplet-Marrow-nan-18m-Lymphocytic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSP90B1 STT3A MGAT2 GAR1 DLG2 GMPR VCAM1 ENTPD4	2.69e-06	190	203	8	9df9b9e91c97e504c189d6055a6aabc54ad17cec
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYT1 DLG2 ACAP3 TRHDE DPYD DPYSL4 SCG3 MEGF10	2.80e-06	191	203	8	a53616c84178eb6c29b48662358765b082df3f97
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH4 NEB FABP3 SRL ELMOD1 NRAP IFITM1	2.80e-06	191	203	8	f932980baa032748857cb367a55c37dd975c693e
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACLY ENPP2 EPB41L3 GMPR GLB1L2 CYFIP2 MTHFD1 SCG3	2.91e-06	192	203	8	5b7093d5af5ae7b0e6d3a464cc56272440ecedad
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ENPP2 CD109 DOCK6 FLT1 DOCK9 GRB10 LIFR RGS6	3.02e-06	193	203	8	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	INSR CD109 SIPA1L2 DOCK6 FLT1 GRB10 CLIC4 ACSL5	3.02e-06	193	203	8	479abb1cd2eb978b8a4fdb900069a6329fc8cade
ToppCell	356C-Fibroblasts-Fibroblast-E\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	IFT140 PDE6A NEB SVEP1 FHAD1 CCDC160 EPB41	3.06e-06	136	203	7	edfd453c9a650d69d05a5a3ab15f7df56349fa86
ToppCell	356C-Fibroblasts-Fibroblast-E-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	IFT140 PDE6A NEB SVEP1 FHAD1 CCDC160 EPB41	3.06e-06	136	203	7	03e4e2353c23ceffde35b2d0aadd15299e3db09f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PARP15 AFF3 WDFY4 ANGPTL1 PIKFYVE CSNK1G3 SETBP1 LYN	3.14e-06	194	203	8	5cd72330c9d9bb21b6c9d5d35085eade101486d1
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 PCDH15 DLG2 PZP VCAM1 TRHDE ASXL3 SETBP1	3.14e-06	194	203	8	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	ACTN1 PCDH15 FLT1 DOCK9 WNT9B GRB10 TECTA SETBP1	3.14e-06	194	203	8	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	Endothelial-endothelial_cell_of_vein\|World / Lineage, Cell type, age group and donor	CD109 CC2D2B KIRREL3 VCAM1 FLT1 WNT9B LHX6 LIFR	3.14e-06	194	203	8	3cbd9622a68e89add90e589867d88c83c5a33476
ToppCell	facs-Thymus-nan-3m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACLY ACTN1 ALB MAP4K4 SLA EEF2 THY1 RAVER1	3.14e-06	194	203	8	66c056232ac216780acf4cc8ea325bd8ed1909c9
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TDRD15 NUP210 PARP15 SELL AFF3 WDFY4 ANGPTL1 SETBP1	3.26e-06	195	203	8	3311a1bf4ed94820b45047d44fc14b14ac72e6fb
ToppCell	Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYFIP1 SIPA1L2 TNS3 GPD2 TGFBR1 VWA5A SLC25A13 LYN	3.26e-06	195	203	8	9d649ac7d2af313481069c95349efc0c68449e2b
ToppCell	3'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ENPP2 NTN1 FLT1 DOCK9 IFITM1 CLIC4 IFITM2 LIFR	3.26e-06	195	203	8	d46955155e5b22d00939eaf5edfb8ac217d06e46
ToppCell	10x5'\|World / Manually curated celltypes from each tissue	GDI1 HSPD1 SELL AFF3 IFITM1 IFITM2 CYFIP2 EEF2	3.26e-06	195	203	8	de28b998793271c4f69ce9e183c3e62d809e9cc8
ToppCell	PBMC-Control-cDC_3\|Control / Compartment, Disease Groups and Clusters	HSP90B1 NUP210 ARFGEF2 WDFY4 CYFIP2 EFHC2 EEF2 ACSL5	3.39e-06	196	203	8	09d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NEB PARP15 SELL AFF3 WDFY4 ANGPTL1 SETBP1 LYN	3.39e-06	196	203	8	de43dd0697e1daf4d50800957cf0b27b54a7a333
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ENPP2 SVEP1 VCAM1 DPYD AFF3 LIFR GYG1 ASXL3	3.52e-06	197	203	8	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ENPP2 SVEP1 VCAM1 DPYD AFF3 LIFR GYG1 ASXL3	3.52e-06	197	203	8	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	ATRX VPS13C INSR VCAM1 DPYD FLT1 SLA LIFR	3.65e-06	198	203	8	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	ATRX VPS13C INSR VCAM1 DPYD FLT1 SLA LIFR	3.65e-06	198	203	8	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	ATRX VPS13C INSR VCAM1 DPYD FLT1 SLA LIFR	3.65e-06	198	203	8	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	mild-B_memory\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PARP15 SEMA4B AFF3 CLIC4 WDFY4 ANGPTL1 PIKFYVE SETBP1	3.79e-06	199	203	8	e6ac9a0959b0de2c6a99298feb7715aa80ade1dd
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	ENPP2 SIPA1L2 DOCK6 MAP4K4 FLT1 DOCK9 LIFR PLEKHA1	3.93e-06	200	203	8	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	Lung_Parenchyma-Control-Myeloid-Macrophage\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ENPP2 CD109 VCAM1 FLT1 DOCK9 WNT9B LHX6 LIFR	3.93e-06	200	203	8	2a1ba87ca4adf351ef8fa2b3154b86a5407b8f2f
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / Treatment groups by lineage, cell group, cell type	ACTN1 VCAM1 FLT1 DOCK9 IFITM1 LHX6 LIFR NCOA7	3.93e-06	200	203	8	b036f5e22c95a3b14391785b6e91aa183b9bc9a8
ToppCell	Lung_Parenchyma-Control-Myeloid-Macrophage-Macrophages-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ENPP2 CD109 VCAM1 FLT1 DOCK9 WNT9B LHX6 LIFR	3.93e-06	200	203	8	98f6a86fbbe5305c71dae91e7278de9813827935
ToppCell	390C-Endothelial_cells-Endothelial-A_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	VCAM1 FLT1 IFITM1 CLIC4 LHX6 LIFR NCOA7 PRKDC	3.93e-06	200	203	8	50b8788494b744e0f0ec8c4d67a1c90ae09dca65
ToppCell	390C-Endothelial_cells-Endothelial-A_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	VCAM1 FLT1 IFITM1 CLIC4 LHX6 LIFR NCOA7 PRKDC	3.93e-06	200	203	8	f5f24273bee3259a4a3be99ba53b88defa1286c0
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Macrophages\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	ENPP2 CD109 VCAM1 FLT1 DOCK9 WNT9B LHX6 LIFR	3.93e-06	200	203	8	d7b89a721988660d8010c804916f5d0ef2520ee2
ToppCell	Lung_Parenchyma-Control-Myeloid-Macrophage-Macrophages\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ENPP2 CD109 VCAM1 FLT1 DOCK9 WNT9B LHX6 LIFR	3.93e-06	200	203	8	1ed1c673184f0c6aae04f90edbb1383b1c1f64d9
ToppCell	Children_(3_yrs)-Immune-mast_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TDRD15 RYR3 PZP KIF2C EFHC2 VWA5A WSCD2	6.11e-06	151	203	7	bbf735c6433c3fc2feedb24ed6f48c51d545fb60
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DAB2IP KIRREL3 VCAM1 FLT1 DOCK9 WNT9B LHX6	1.14e-05	166	203	7	f7926ee266dcbf10df375cd921f1db5a2fa604f8
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH1 MYH4 MYH8 NEB FABP3 SRL NRAP	1.18e-05	167	203	7	d78356bf0c473816dbabaee51984940bd822f84e
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells\|GI_small-bowel / Manually curated celltypes from each tissue	MYT1 MAP4K4 AFF3 WDFY4 ANGPTL1 SETBP1 LYN	1.23e-05	168	203	7	8e025bb0541746e232b77ac0e31412ae71420c47
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_B\|GI_small-bowel / Manually curated celltypes from each tissue	MYT1 MAP4K4 AFF3 WDFY4 ANGPTL1 SETBP1 LYN	1.23e-05	168	203	7	5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NEB SVEP1 RYR3 CFAP54 IFITM1 GYG1 WSCD2	1.28e-05	169	203	7	16c52a0f6d96ecc1832922fce9b39691849f0d73
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYT1 MET KIRREL3 TNS3 RGS12 FAM169A PLEKHA1	1.33e-05	170	203	7	5d5f208682be21ed58320f5fc083a7898f8712da
ToppCell	Immune-mast_cell\|World / Lineage, Cell type, age group and donor	TDRD15 RYR3 GMPR PZP EFHC2 VWA5A WSCD2	1.43e-05	172	203	7	6e8e0aac5a20dbc789bf8c6916833bb8709a411a
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	KIRREL3 MYO3A CFAP54 SIPA1L2 VCAM1 THY1 WSCD2	1.43e-05	172	203	7	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b-Inhibitory_Gad1Gad2_Id2.Bcl11b_(Interneuron,_Neurogliaform2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH1 MYH8 MYO3A LHX6 SLC17A1	1.47e-05	68	203	5	cfd75c373e10b3761666ccd445ba74755efeb95f
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH1 MYH8 MYO3A LHX6 SLC17A1	1.47e-05	68	203	5	c25fb921dc83eecdc337353894829ae6b5192353
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b-Inhibitory_Gad1Gad2_Id2.Bcl11b_(Interneuron,_Neurogliaform2)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH1 MYH8 MYO3A LHX6 SLC17A1	1.47e-05	68	203	5	712f5f4d3a1e0c0db1a340332876206b93bdac31
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR3 MET SLC9B1 NTN1 MPP7 WNT9B THY1	1.60e-05	175	203	7	f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GALE SRL KIF2C KIF23 EPG5 THY1 UBR3	1.60e-05	175	203	7	8958c5c30437d20a4abd70d7527990f7e2a68b93
Drug	formycin triphosphate	MYH1 MYH2 MYH4 MYH8 MYO1A MYO3A	5.68e-06	51	201	6	CID000122274
Drug	creatine	MYH1 MYH2 MYH4 MYH8 RYR3 FABP3 MYO3A VDAC2 ARG1 MTR	8.84e-06	193	201	10	CID000000586
Drug	blebbistatin	MYH1 MYH2 MYH4 MYH8 MYO1A ACTN1 MYO3A KIF23	9.03e-06	116	201	8	CID003476986
Drug	Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HG-U133A	EPB41L3 COG5 DPYD DOCK9 IFITM1 GLB1L2 IDS IBTK TRAPPC10 PRKDC	9.25e-06	194	201	10	1924_DN
Drug	LY294002	MYH1 MYH2 MYH4 MYH8 ENPP2 INSR ACTN1 MET MYO3A C5 VCAM1 FLT1 ANXA5 GRB10 SLA PIKFYVE IL36RN THY1 PRKDC LYN	1.13e-05	748	201	20	CID000003973
Drug	purealin	MYH1 MYH2 MYH4 MYH8 MYO1A MYO3A	1.21e-05	58	201	6	CID006419303
Drug	NSC339663	MYH1 MYH2 MYH4 MYH8 MYO1A INSR ACTN1 RAB8A MYO3A PIKFYVE THY1	1.47e-05	250	201	11	CID000003892
Drug	AC1L1IZ2	MYH1 MYH2 MYH4 HSP90B1 MYH8 MYO1A INSR PGK2 RYR3 MYO3A HSPD1 KIF23	1.78e-05	304	201	12	CID000004795
Drug	crystal violet	GMPR VCAM1 HSPD1 SELL ANXA5 MCOLN1	1.96e-05	63	201	6	CID000003468
Drug	glycolide	STT3A PZP SETBP1	2.31e-05	7	201	3	CID000065432
Drug	Linoleic Acid	ACLY INSR FABP3 ALB VCAM1 ANXA5 PPARGC1B	2.82e-05	99	201	7	ctd:D019787
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH8	4.00e-07	10	198	4	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH8	4.00e-07	10	198	4	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH8	4.00e-07	10	198	4	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH8	4.00e-07	10	198	4	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH8	4.00e-07	10	198	4	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH8	4.00e-07	10	198	4	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH8	4.00e-07	10	198	4	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH8	4.00e-07	10	198	4	DOID:0080326 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH8	9.33e-07	12	198	4	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH8	9.33e-07	12	198	4	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH8	1.34e-06	13	198	4	DOID:397 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH8	2.53e-06	15	198	4	DOID:0050646 (implicated_via_orthology)
Disease	coronary artery disease	DAB2IP TDRD15 IFT140 CD109 TTC34 SVEP1 NUP210 C5 TMED10 COG5 DOCK6 TNS3 CHST3 DPYD FLT1 DOCK9 UBE3B WNT9B ARFGEF2 EPG5 MSL2 LNPEP SNRPD2	5.91e-06	1194	198	23	EFO_0001645
Disease	Down syndrome (is_marker_for)	ERCC2 FABP3 HSPD1 MTHFD1	1.31e-05	22	198	4	DOID:14250 (is_marker_for)
Disease	myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH8 MEGF10	1.75e-05	48	198	5	DOID:423 (implicated_via_orthology)
Disease	Myopathy	FABP3 ALB ARG1 MEGF10	4.70e-05	30	198	4	C0026848
Disease	cancer (implicated_via_orthology)	GDI1 PGK2 TRAPPC1 THG1L DLG2 ACAP3 FLT1 PPP2R5B LYN	8.87e-05	268	198	9	DOID:162 (implicated_via_orthology)
Disease	Drug habituation	INSR PCDH15 TMPRSS7 MPP7 AFF3 AGBL4	1.30e-04	115	198	6	C0013170
Disease	Drug abuse	INSR PCDH15 TMPRSS7 MPP7 AFF3 AGBL4	1.30e-04	115	198	6	C0013146
Disease	Prescription Drug Abuse	INSR PCDH15 TMPRSS7 MPP7 AFF3 AGBL4	1.30e-04	115	198	6	C4316881
Disease	Substance-Related Disorders	INSR PCDH15 TMPRSS7 MPP7 AFF3 AGBL4	1.30e-04	115	198	6	C0236969
Disease	Drug Use Disorders	INSR PCDH15 TMPRSS7 MPP7 AFF3 AGBL4	1.30e-04	115	198	6	C0013222
Disease	Drug Dependence	INSR PCDH15 TMPRSS7 MPP7 AFF3 AGBL4	1.30e-04	115	198	6	C1510472
Disease	Substance Dependence	INSR PCDH15 TMPRSS7 MPP7 AFF3 AGBL4	1.30e-04	115	198	6	C0038580
Disease	Substance Use Disorders	INSR PCDH15 TMPRSS7 MPP7 AFF3 AGBL4	1.30e-04	115	198	6	C0038586
Disease	Organic Mental Disorders, Substance-Induced	INSR PCDH15 TMPRSS7 MPP7 AFF3 AGBL4	1.30e-04	115	198	6	C0029231
Disease	chromosome 15q11.2 deletion syndrome (implicated_via_orthology)	CYFIP1 CYFIP2	1.34e-04	3	198	2	DOID:0060393 (implicated_via_orthology)
Disease	Substance abuse problem	INSR PCDH15 TMPRSS7 MPP7 AFF3 AGBL4	1.36e-04	116	198	6	C0740858
Disease	Uremia	VCAM1 FLT1 TGFBR1	1.89e-04	17	198	3	C0041948
Disease	Squamous cell carcinoma	ERCC2 MET VDAC2 SFN ANXA5 PRKDC	1.96e-04	124	198	6	C0007137
Disease	Neural tube defects, folate-sensitive	MTHFD1 MTR	2.66e-04	4	198	2	cv:C1866558
Disease	Headache, fasting blood insulin measurement	AFF3 GRB10	2.66e-04	4	198	2	EFO_0004466, HP_0002315
Disease	Neural tube defect, folate-sensitive	MTHFD1 MTR	2.66e-04	4	198	2	C1866558
Disease	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	MTHFD1 MTR	2.66e-04	4	198	2	601634
Disease	urate measurement, bone density	DAB2IP KIRREL3 DLG2 CAPS2 MPP7 GRIN2C ENTPD4 RGS6 LZTS1 ASB3 UGGT2 SEL1L2 PRKDC	3.03e-04	619	198	13	EFO_0003923, EFO_0004531
Disease	Alzheimer's disease (is_marker_for)	ERCC2 INSR FABP3 TMED10 HSPD1 SELL ANXA5 EEF2	3.64e-04	257	198	8	DOID:10652 (is_marker_for)
Disease	sarcoma (is_marker_for)	ATRX MET	4.42e-04	5	198	2	DOID:1115 (is_marker_for)
Disease	Adenocarcinoma of lung (disorder)	GAR1 ALB SFN FLT1 ANXA5 ARG1 PRKDC	5.05e-04	206	198	7	C0152013
Disease	age at onset, Myopia	INSR DLG2 PZP GPD2 FLT1 TGFBR1	5.44e-04	150	198	6	EFO_0004847, HP_0000545
Disease	X-11423--O-sulfo-L-tyrosine measurement	MYT1 PCDH15	6.60e-04	6	198	2	EFO_0021231
Disease	extraversion	PCDH15 WSCD2	6.60e-04	6	198	2	EFO_0004317
Disease	spina bifida (is_implicated_in)	MTHFD1 MTR	6.60e-04	6	198	2	DOID:0080016 (is_implicated_in)
Disease	Liver carcinoma	ACLY MET PZP TALDO1 VCAM1 SFN KIF2C DPYD KIF23 LIFR THY1	6.73e-04	507	198	11	C2239176
Disease	type 2 diabetes mellitus (implicated_via_orthology)	INSR AFF1 AFF3 LNPEP MTR	7.26e-04	105	198	5	DOID:9352 (implicated_via_orthology)
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	TDRD15 MYH2 INSR SLC9B1 SPG11 RGS12 TYW1B	7.85e-04	222	198	7	EFO_0008317, EFO_0020943
Disease	liver disease (biomarker_via_orthology)	DPYD ARG1	9.20e-04	7	198	2	DOID:409 (biomarker_via_orthology)
Disease	Prostatic Neoplasms	DAB2IP HSP90B1 ERCC2 MET U2AF1 POLK CLIC4 LIFR RNASEL LZTS1 NCOA7 PRKDC	9.89e-04	616	198	12	C0033578
Disease	Malignant neoplasm of prostate	DAB2IP HSP90B1 ERCC2 MET U2AF1 POLK CLIC4 LIFR RNASEL LZTS1 NCOA7 PRKDC	9.89e-04	616	198	12	C0376358
Disease	Hematological Disease	GAR1 MTR	1.22e-03	8	198	2	C0018939
Disease	cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH8	1.35e-03	71	198	4	DOID:0050700 (implicated_via_orthology)
Disease	hepatocellular carcinoma (is_implicated_in)	ERCC2 RYR3 MET ALB MAP4K4 ARG1	1.44e-03	181	198	6	DOID:684 (is_implicated_in)
Disease	Drug-Induced Liver Disease	GDI1 SULT1C3 ALB PZP TALDO1 FLT1 ARG1 TGFBR1 PRKDC	1.72e-03	404	198	9	C0860207
Disease	Drug-Induced Acute Liver Injury	GDI1 SULT1C3 ALB PZP TALDO1 FLT1 ARG1 TGFBR1 PRKDC	1.72e-03	404	198	9	C3658290
Disease	Hepatitis, Toxic	GDI1 SULT1C3 ALB PZP TALDO1 FLT1 ARG1 TGFBR1 PRKDC	1.72e-03	404	198	9	C0019193
Disease	Chemically-Induced Liver Toxicity	GDI1 SULT1C3 ALB PZP TALDO1 FLT1 ARG1 TGFBR1 PRKDC	1.72e-03	404	198	9	C4279912
Disease	Chemical and Drug Induced Liver Injury	GDI1 SULT1C3 ALB PZP TALDO1 FLT1 ARG1 TGFBR1 PRKDC	1.72e-03	404	198	9	C4277682
Disease	Hepatitis, Drug-Induced	GDI1 SULT1C3 ALB PZP TALDO1 FLT1 ARG1 TGFBR1 PRKDC	1.72e-03	404	198	9	C1262760
Disease	preeclampsia	FLT1 RGS6 LZTS1 LNPEP	1.90e-03	78	198	4	EFO_0000668
Disease	unipolar depression, alcohol dependence	NEB TRHDE HSPD1 GRB10	1.90e-03	78	198	4	EFO_0003761, MONDO_0007079
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH8	2.09e-03	80	198	4	DOID:12930 (implicated_via_orthology)
Disease	Nonsyndromic Deafness	MET MYO3A PCDH15 TECTA	2.19e-03	81	198	4	C3711374
Disease	Leukoencephalopathy	DPYD MTR	2.37e-03	11	198	2	C0270612
Disease	Semantic-Pragmatic Disorder	DPYD SETBP1	2.37e-03	11	198	2	C0454655
Disease	Auditory Processing Disorder, Central	DPYD SETBP1	2.37e-03	11	198	2	C0751257
Disease	Language Delay	DPYD SETBP1	2.37e-03	11	198	2	C0023012
Disease	Language Development Disorders	DPYD SETBP1	2.37e-03	11	198	2	C0023014
Disease	Occupational Diseases	ERCC2 ALB	2.37e-03	11	198	2	C0028797
Disease	Speech Delay	DPYD SETBP1	2.37e-03	11	198	2	C0241210
Disease	Malignant neoplasm of breast	MYH1 CD109 EPB41L3 AFF1 DPYD FLT1 ARFGEF2 TECTA MCOLN1 UBLCP1 EPG5 METTL6 PPARGC1B EEF2 SETBP1 MTR	2.52e-03	1074	198	16	C0006142
Disease	phospholipid measurement	TDRD15 CFAP54 DLG2 POLK DOCK6	2.60e-03	140	198	5	EFO_0004639
Disease	lung adenocarcinoma (is_marker_for)	HSP90B1 ATRX MAP4K4 EEF2	2.61e-03	85	198	4	DOID:3910 (is_marker_for)
Disease	myocardial infarction	DAB2IP TDRD15 CD109 TTC34 AP3D1 FLT1 DOCK9 IFITM2	2.62e-03	350	198	8	EFO_0000612
Disease	high grade glioma (is_implicated_in)	KDM5B ERCC2 ATRX	2.82e-03	42	198	3	DOID:3070 (is_implicated_in)
Disease	autistic disorder (is_implicated_in)	MET HSPD1 MTR	2.82e-03	42	198	3	DOID:12849 (is_implicated_in)
Disease	Congenital myopathy (disorder)	NEB CACNA1S	2.83e-03	12	198	2	C0270960
Disease	cognitive function measurement, self reported educational attainment	PEF1 GPD2 DPYD AFF3 ARFGEF2 SLC17A1 SCG3 RBM5	2.86e-03	355	198	8	EFO_0004784, EFO_0008354
Disease	Mammary Carcinoma, Human	CD109 EPB41L3 DPYD FLT1 UBLCP1 METTL6 PPARGC1B EEF2 SETBP1 MTR	3.03e-03	525	198	10	C4704874
Disease	Mammary Neoplasms, Human	CD109 EPB41L3 DPYD FLT1 UBLCP1 METTL6 PPARGC1B EEF2 SETBP1 MTR	3.03e-03	525	198	10	C1257931
Disease	Mammary Neoplasms	CD109 EPB41L3 DPYD FLT1 UBLCP1 METTL6 PPARGC1B EEF2 SETBP1 MTR	3.11e-03	527	198	10	C1458155
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	MET MYO3A HSPD1 FLT1 EEF2	3.30e-03	148	198	5	C0279702
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	TDRD15 AFF1 SPG11 MSL2 TYW1B	3.49e-03	150	198	5	EFO_0004611, EFO_0020947
Disease	Breast Carcinoma	CD109 EPB41L3 DPYD FLT1 UBLCP1 METTL6 PPARGC1B EEF2 SETBP1 MTR	3.60e-03	538	198	10	C0678222
Disease	Childhood Ataxia with Central Nervous System Hypomyelinization	DPYD MTR	3.87e-03	14	198	2	C1858991
Disease	Kuhnt-Junius degeneration (is_marker_for)	FLT1 ANXA5	3.87e-03	14	198	2	DOID:10873 (is_marker_for)
Disease	systemic lupus erythematosus (is_marker_for)	VCAM1 HSPD1 SELL	3.88e-03	47	198	3	DOID:9074 (is_marker_for)
Disease	neuropathic pain	TTC34 GPD2 ASB3	3.88e-03	47	198	3	EFO_0005762
Disease	cardiovascular disease	TDRD15 DCDC1 INSR SVEP1 SLC9B1 DLG2 SIPA1L2 POLR1A CLIC4	3.89e-03	457	198	9	EFO_0000319
Disease	upper face morphology measurement	ENPP2 TTC34 ALB WNT9B	4.19e-03	97	198	4	EFO_0010949
Disease	colorectal cancer (is_marker_for)	DAB2IP ERCC2 MAP4K4 KIF2C EEF2	4.24e-03	157	198	5	DOID:9256 (is_marker_for)
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	TDRD15 SLC9B1 AFF1 SPG11 RGS12 TYW1B	4.24e-03	225	198	6	EFO_0008317, EFO_0020947
Disease	hearing impairment	MYO1A MYO3A PCDH15 TECTA	4.35e-03	98	198	4	C1384666
Disease	developmental disorder of mental health (implicated_via_orthology)	DAB2IP DLG2 GRIN2C	4.37e-03	49	198	3	DOID:0060037 (implicated_via_orthology)
Disease	Hepatitis	ENPP2 ALB	4.44e-03	15	198	2	C0019158
Disease	diastolic blood pressure change measurement	CD109 AFF1 WSCD2	4.63e-03	50	198	3	EFO_0006945
Disease	pancreatic cancer (is_marker_for)	MET ALB VCAM1 DPYD	4.84e-03	101	198	4	DOID:1793 (is_marker_for)
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	MYO3A PCDH15 TECTA	4.89e-03	51	198	3	cv:CN043650
Disease	proliferative diabetic retinopathy (is_marker_for)	ENPP2 FLT1	5.05e-03	16	198	2	DOID:13207 (is_marker_for)
Disease	lung small cell carcinoma (is_marker_for)	ATRX EEF2	5.05e-03	16	198	2	DOID:5409 (is_marker_for)
Disease	diastolic blood pressure, body mass index	CACNA1S EFHC2	5.05e-03	16	198	2	EFO_0004340, EFO_0006336
Disease	Spondyloepiphyseal Dysplasia	CHST3 FLT1	5.05e-03	16	198	2	C0038015

Protein segments in the cluster

Peptide	Gene	Start	Entry
AYKKGAALIRMLANF	TRHDE	526	Q9UKU6
MNGKLFDELTASYKL	PPP2R5B	431	Q15173
ADAMVEKFGKALNYA	AFF3	991	P51826
GKLSKDQFALAMYFI	EPS15L1	326	Q9UBC2
FLENAKKLSMYGVDL	EPB41	386	P11171
FYKLRLSKMDFKSFG	EPG5	1901	Q9HCE0
YGMITDLFIDKFKFK	BBS7	671	Q8IWZ6
SFGMDANVLKYKSLQ	AGBL3	946	Q8NEM8
YKATGKMKIFQSFDS	CFAP54	2151	Q96N23
TAGMDIFAKFSAYIK	CLIC4	116	Q9Y696
KRMDKAIGYSFAIVG	ELMOD1	226	Q8N336
ASFKILAGDKNYITM	ACTN1	831	P12814
KNYAEAKDVFLGMFL	ALB	341	P02768
YVRKAFMKLDFNKSG	CAPS2	521	Q9BXY5
FAMLTAPKAAAYARK	C2orf80	136	Q0P641
AGDAESRVFYLKMKG	SFN	111	P31947
FLGDSARFNKEVMYA	ARFGEF2	696	Q9Y6D5
DRKMFLFGTYLTKNG	ARL9	151	Q6T311
ASKFQAIRGMISEYK	ANKRD62	246	A6NC57
MEGYLFKRASNAFKT	ACAP3	271	Q96P50
KMSEAYSAKIALFGA	DPYD	181	Q12882
KQFTTLDRDKDMYAG	ANGPTL1	416	O95841
KLRFAFSIYDMDKDG	PPP3R2	91	Q96LZ3
KKADISYMRFGELEG	CDADC1	451	Q9BWV3
YAKDVKFGADARALM	HSPD1	26	P10809
LRKVFDKYMTISGFQ	ANXA5	206	P08758
DLYMALQAFSFKTKD	DHX29	126	Q7Z478
RKAVKYDLGSSFMNK	CC2D2B	266	Q6DHV5
EKFFERFYGEKLGMS	ASXL3	351	Q9C0F0
DVASFFGKRRYICMK	ADNP2	1086	Q6IQ32
KYFSMTEVDRLGIGK	ARG1	196	P05089
EVMSASKFTFKRIGY	AP3D1	81	O14617
RFNMELYKLSGRKSG	NTN1	351	O95631
SGFLMKKELDYFAKA	PGK2	186	P07205
GFAEYMKKDSAARAK	RAVER1	176	Q8IY67
GFVEYMKKDFAAKAR	RAVER2	186	Q9HCJ3
DIYSFLKGMGLKVFT	PZP	661	P20742
LDYGIKFMETSAKAN	RAB8A	141	P61006
VLTMKDDGTFYRFQA	RGS6	101	P49758
KYFFMSPCDKFRAKG	MCOLN1	46	Q9GZU1
SQKFTDKRIGYLGAM	AP1G1	76	O43747
FGLDRSYMGKSLKDL	MEGF10	996	Q96KG7
AKYFPFMDLKLRAAS	NUP210	1011	Q8TEM1
SAYKRAAQFLRKMAD	CYFIP1	186	Q7L576
LANFAKFGSKEEYMS	DAB2IP	561	Q5VWQ8
FARGDIMVAYKTFLD	DCDC1	601	M0R2J8
KFFSFIEGCLVKNYM	MAP4K4	261	O95819
FYDSMKKRDLSASLN	PARP15	456	Q460N3
MSNLRKLFLAFGYDD	PRAMEF17	231	Q5VTA0
YGDKAFEVAKMASVT	GPD2	501	P43304
SSKMGKSEDFFYIKV	LZTS1	56	Q9Y250
MLFYSFFKSLVGKDV	LSM2	1	Q9Y333
AFAYSVKSRDRKMVG	IFITM2	76	Q01629
ASRSFYGMADKVDVK	MGAT2	296	Q10469
DIKYRQDFNKMKGAA	NRAP	331	Q86VF7
SSRFGKYMDIEFDFK	MYO1A	156	Q9UBC5
ADFIYKSMVQKFLLG	MYO1A	776	Q9UBC5
SDGVLKDLSEFYRKM	IBTK	916	Q9P2D0
GLKFDSKYMNFRVRA	FSD1L	266	Q9BXM9
RMGDSKFFREYEGKS	KCNT1	546	Q5JUK3
LVDSKNFDDYMKSLG	FABP3	11	P05413
RRNFKKFMEKDSYGS	EFHC2	416	Q5JST6
KFMEKDSYGSKSNIL	EFHC2	421	Q5JST6
AVGALAKAVYEKMFL	MYH8	426	P13535
AVGALAKAVYEKMFL	MYH2	426	Q9UKX2
ATFYNRKDGKPFDEM	PDE6A	401	P16499
SKEGKMFIKALFDYN	MPP7	226	Q5T2T1
KSFSMIKEGDYNPLF	SELL	321	P14151
AIKMGRYKESFVSAG	EPHB3	936	P54753
KTDYGLMVFADKRFA	ERCC2	671	P18074
SSYEDFLDARFKTMK	LNPEP	506	Q9UIQ6
EIFCKMDYFSRFGTK	LHX6	116	Q9UPM6
FYFGLRFMAADDKIK	KCNU1	151	A8MYU2
DYTLRTFGEMADAFK	KDM5B	376	Q9UGL1
AVGALAKAVYDKMFL	MYH1	426	P12882
AEIADGMAYLNAKKF	INSR	1141	P06213
SAYKRAAQFLRKMAD	CYFIP2	186	Q96F07
KLFTDLFDRKGYMFD	CSNK1G3	306	Q9Y6M4
SYMANGEKKLEAFAV	MSL2	501	Q9HCI7
ADSYKDAVRKAMFAR	RBM5	796	P52756
NMFDKTKSGRIDVYG	PEF1	161	Q9UBV8
MELYLGAKESKSFTF	IL36RN	86	Q9UBH0
GAKESKSFTFYRRDM	IL36RN	91	Q9UBH0
AKEMYFTKITDFVGN	MGAT4D	261	A6NG13
GLYDHAMLRFKASSK	METTL6	191	Q8TCB7
LKLGFMSAFVKASAF	DLST	276	P36957
DKIYFMAGSSRKEAE	HSP90B1	536	P14625
KKFYIGGVSEDARMF	PCDH15	1146	Q96QU1
SSMFLKQAFEGEYPK	COG5	401	Q9UP83
FYGRKMAQVFDLKGS	PIKFYVE	1941	Q9Y2I7
GALQRLFKKYSFMAV	GALE	71	Q14376
VKEKGVNSFLVFMAY	DPYSL4	156	O14531
DSSENYIKMKTFEGF	ASB3	66	Q9Y575
AEYEAEKKGLTMRFN	ATRX	2276	P46100
LQLKAYFLGSKSSMA	CD109	441	Q6YHK3
SYRMGAEGKFDLKLA	HECTD1	1321	Q9ULT8
MKAYLKSAEGFFVLN	FHAD1	1	B1AJZ9
MYKQAEAAGFKASKS	TTC26	106	A0AVF1
DYMGADSFDNIKRKL	GYG1	331	P46976
FYFDLNSDSMKGLLR	DOCK6	296	Q96HP0
RFAFELKMQDKSSYL	DOCK9	246	Q9BZ29
SLEAKNEMGSKYKQF	CPLANE1	1081	Q9H799
ILKLMAFKARGYFGD	CACNA1S	1166	Q13698
QKGYMFDIKTSERTF	GAB4	116	Q2WGN9
FSKSKRMPITYDNGF	C5	111	P01031
VNFSKTKSLYRDGMA	AGBL4	101	Q5VU57
SKGMEEIYNLSSRKF	CCDC160	41	A6NGH7
FSDAKTMYEVFQRGL	ACSL5	71	Q9ULC5
DTMFLRKKYRGKDFG	FAM169A	181	Q9Y6X4
YMAKGSLLDFLKSDE	LYN	321	P07948
KDKFRRMNEGQVYSF	KIRREL3	36	Q8IZU9
TMASESKFLFRKNYA	GRB10	236	Q13322
VRAMFDYDKSKDSGL	DLG2	541	Q15700
DIKDIYKRMAGTAFD	GDI1	416	P31150
AKYMKLRDFFGSISG	GLB1L2	356	Q8IW92
YSLDMKKSFFQRFGL	GLB1L2	521	Q8IW92
KQFAEMYVAKFAAKG	EEF2	226	P13639
KMKTSASPFFLAVGY	IDS	211	P22304
FERNGRKLKLFYGMS	GMPR	256	P36959
FAFEDMYNADRKVKG	CEP295	306	Q9C0D2
MKNIIGFYTKGRALD	IFT140	1266	Q96RY7
KGIYAMASRDVFLLK	KIF2C	371	Q99661
GMEKFFNIKCRYSGL	MTHFD1	676	P11586
VDGFRASYMKKGSKV	ENPP2	171	Q13822
FLENAKKLSMYGVDL	EPB41L3	286	Q9Y2J2
FYFGKGERDTSKMRV	LIFR	761	P42702
LFKNYFDGEGKVRMI	KIF23	396	Q02241
AFAYSVKSRDRKMVG	IFITM1	56	P13164
GSFMIRESETKKGFY	SLA	106	Q13239
RDFYFSVKLSENMKA	GAR1	121	Q9NY12
KTKAFFMLDGILSKY	MET	816	P08581
FTVKVADFGLARDMY	MET	1216	P08581
YIFSFDKMLDDRGNT	RARS1	516	P54136
IIYFARKANMKGSYS	VCAM1	716	P19320
KMDKTGASFKYAVES	GFM2	196	Q969S9
SFGMYSAEELKKLSV	POLR1A	16	O95602
GEIIDFYKMKAASEA	SEPTIN14	401	Q6ZU15
DKDYQKKMAGSTLTF	SULT1C3	286	Q6IMI6
NKDRYISKMFLRGDS	SNRPD2	91	P62316
MDKYAVFKGIAADKS	SYNRG	511	Q9UMZ2
AEMLNVSKSGRFYVK	TDRD15	1531	B5MCY1
FLKMNCRYFTDGKGV	NCOA7	221	Q8NI08
DTFAYKRSFKMADLG	PLEKHG4	966	Q58EX7
YLLFAKAADMGNLKA	SEL1L2	131	Q5TEA6
VLRMGGDYNAAKFTK	ENTPD4	441	Q9Y227
FSGIYSTKKMIGFAL	SLC17A1	101	Q14916
AGSRKFAKLIMAGNY	MTR	381	Q99707
YMLFKNASGKRRFLL	SLC46A3	246	Q7Z3Q1
FTMKDVQRVFSGLYK	SEMA4B	361	Q9NPR2
SGKSKYEAMDFDSLL	PPARGC1B	1001	Q86YN6
FTAFMEAAVYGKVKA	RNASEL	126	Q05823
MTKFGFLRLSYEKQD	STT3A	1	P46977
DDYFARKFKAINGNM	SIPA1L2	31	Q9P2F8
AVGALAKAIYEKMFL	MYH4	426	Q9Y623
MYDKLSENSVAKGVF	VPS8	601	Q8N3P4
YSRKGFLFKSFAMSA	SUPT5H	366	O00267
ADQALDRFAMKKFYD	TNS3	131	Q68CZ2
DRFAMKKFYDDKVSA	TNS3	136	Q68CZ2
GFKSFEMFYKAARCD	SVEP1	796	Q4LDE5
KHFESFKRADIYAMG	TGFBR1	391	P36897
AAAKMFSKAFDSGII	ACLY	941	P53396
MTDRVGKAFKYLEAV	AFF1	981	P51825
FLKYASIEKNGEFFM	SLC25A13	21	Q9UJS0
VLASRMVAFAGKYKT	CHST3	306	Q7LGC8
SAYNMKLAKFSFQID	SPG11	321	Q96JI7
QEGSFITKMALYKNA	TECTA	1926	O75443
RSLGKYTDFKMFSDE	POGLUT3	206	Q7Z4H8
NLQKGISFMDYLSDK	UHRF1BP1L	956	A0JNW5
DMKDGFLAFQTSRYK	TRAPPC1	56	Q9Y5R8
FNLMKFDSYTRFLKS	RGS12	811	O14924
FLEGKDASAFAAKMR	PXMP2	131	Q9NR77
TKGKFAFTTEDYDMF	TMED10	91	P49755
KTESKDAFYFAGMFR	TMPRSS7	101	Q7RTY8
ELDASSMEKRFAYKF	RYR3	2806	Q15413
LGATMAKSKFEYVRD	THG1L	26	Q9NWX6
YATNGAKFLKRHMFD	SPATA20	531	Q8TB22
LQTYKDKMTFFSDGE	SRL	351	Q86TD4
MEATKGSRFYGNELK	POLK	41	Q9UBT6
QKLVEKLYSGMFSAD	WDFY4	1966	Q6ZS81
MKVLYLSAFTSKDEG	THY1	86	P04216
LAGYQMTFDSAKSKL	VDAC2	161	P45880
KAKTFQMDDYSLCGL	VWA5A	651	O00534
YADMSKVDGKLSFKV	VPS13C	1686	Q709C8
KAAFQYGIKMSEGRK	IK	501	Q13123
TYLLMCFAGFSFKEK	SLC9B1	416	Q4ZJI4
MAEYLASIFGTEKDK	U2AF1	1	Q01081
MAEYLASIFGTEKDK	U2AF1L4	1	Q8WU68
SAAKTKGFEVYLAEM	YLPM1	1946	P49750
EGMTELYFQLKSKDF	PRKDC	2406	P78527
YLQLFEFVGKMLGKA	UBE3B	771	Q7Z3V4
AMDRYTAFLKQSGKF	UBR3	881	Q6ZT12
KAFKYMSVIQAFLGS	XKR3	161	Q5GH77
EFYSKKNTIMFDDIG	UBLCP1	241	Q8WVY7
KFSYKTIVMGASFRN	TALDO1	226	P37837
YRNKGSFDEAAKIME	TTC37	396	Q6PGP7
GFALALFMKGLYKES	TTC37	1056	Q6PGP7
RALRGVSFFDYKKMT	WSCD2	141	Q2TBF2
RSAKFVGKDLAEFYM	TRAPPC10	476	P48553
EERKAGASFYKMTGL	UGGT2	601	Q9NYU1
MGLLKRGFKETAFLY	WNT9B	106	O14905
TFTMEKRGFYESLAK	PLEKHA1	336	Q9HB21
GSSDDVRYVNAFKFM	FLT1	1206	P17948
TTQAGEKMYFRKFFK	TRAPPC13	151	A5PLN9
FGTYREKDIQAFKMN	SETBP1	1306	Q9Y6X0
QEYFVRKSNAKKGMF	TOPBP1	676	Q92547
RCYGFLGQKKTAMFD	TTC34	186	A8MYJ7
GNKEDYDLSKMRDFI	SCG3	426	Q8WXD2
FRFGKTYLKGMRDAV	TYW1B	116	Q6NUM6
SALAKLKFANSYRME	DYNLT2	76	Q8IZS6
NDNSSRFGKYLEMKF	MYO3A	481	Q8NEV4
RFGKYLEMKFTSSGA	MYO3A	486	Q8NEV4
DYASFDAQVFGKRML	MYT1	586	Q01538
VSELIYKSDFFKMQG	NEB	5051	P20929
TSLKMGKLDAFIYDA	GRIN2C	716	Q14957